CN103168883A - 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 - Google Patents
可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 Download PDFInfo
- Publication number
- CN103168883A CN103168883A CN2012103764624A CN201210376462A CN103168883A CN 103168883 A CN103168883 A CN 103168883A CN 2012103764624 A CN2012103764624 A CN 2012103764624A CN 201210376462 A CN201210376462 A CN 201210376462A CN 103168883 A CN103168883 A CN 103168883A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- weight portion
- effect
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013616 tea Nutrition 0.000 title claims abstract description 56
- 230000036039 immunity Effects 0.000 title claims abstract description 40
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 29
- 239000008187 granular material Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 17
- 244000000010 microbial pathogen Species 0.000 title abstract description 4
- 229920002472 Starch Polymers 0.000 claims abstract description 86
- 239000008107 starch Substances 0.000 claims abstract description 86
- 235000019698 starch Nutrition 0.000 claims abstract description 86
- 239000000284 extract Substances 0.000 claims abstract description 84
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 55
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 54
- 229920001353 Dextrin Polymers 0.000 claims abstract description 49
- 239000004375 Dextrin Substances 0.000 claims abstract description 49
- 235000019425 dextrin Nutrition 0.000 claims abstract description 49
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 48
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 47
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 32
- 235000008397 ginger Nutrition 0.000 claims abstract description 32
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 17
- 229940094952 green tea extract Drugs 0.000 claims abstract description 8
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 8
- 229940105902 mint extract Drugs 0.000 claims abstract description 8
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 244000269722 Thea sinensis Species 0.000 claims description 41
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 35
- 230000001717 pathogenic effect Effects 0.000 claims description 32
- 241000522254 Cassia Species 0.000 claims description 26
- 235000009569 green tea Nutrition 0.000 claims description 26
- 235000013399 edible fruits Nutrition 0.000 claims description 25
- 244000246386 Mentha pulegium Species 0.000 claims description 24
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 24
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 24
- 235000001050 hortel pimenta Nutrition 0.000 claims description 24
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 18
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 18
- 244000003416 Asparagus officinalis Species 0.000 claims description 17
- 235000015468 Lycium chinense Nutrition 0.000 claims description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 16
- -1 lixiviate 2-8 hour Substances 0.000 claims description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 14
- 244000241872 Lycium chinense Species 0.000 claims description 14
- 238000005728 strengthening Methods 0.000 claims description 14
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 241000213006 Angelica dahurica Species 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 6
- 235000020985 whole grains Nutrition 0.000 claims description 3
- 240000002045 Guettarda speciosa Species 0.000 claims 2
- 210000004369 blood Anatomy 0.000 abstract description 57
- 239000008280 blood Substances 0.000 abstract description 57
- 239000003814 drug Substances 0.000 abstract description 22
- 239000002002 slurry Substances 0.000 abstract description 19
- 235000000346 sugar Nutrition 0.000 abstract description 19
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 15
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 150000002632 lipids Chemical class 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 5
- 230000005906 menstruation Effects 0.000 abstract description 4
- 210000004243 sweat Anatomy 0.000 abstract description 4
- 235000017803 cinnamon Nutrition 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 235000020230 cinnamon extract Nutrition 0.000 abstract 1
- 229940002508 ginger extract Drugs 0.000 abstract 1
- 235000020708 ginger extract Nutrition 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 148
- 241000699666 Mus <mouse, genus> Species 0.000 description 31
- 230000002401 inhibitory effect Effects 0.000 description 31
- 239000000047 product Substances 0.000 description 28
- 238000000034 method Methods 0.000 description 27
- 244000241838 Lycium barbarum Species 0.000 description 25
- 235000015459 Lycium barbarum Nutrition 0.000 description 25
- 241000234314 Zingiber Species 0.000 description 25
- 230000006870 function Effects 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 22
- 241000700159 Rattus Species 0.000 description 21
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 20
- 238000002347 injection Methods 0.000 description 20
- 239000007924 injection Substances 0.000 description 20
- 230000009471 action Effects 0.000 description 19
- 239000000853 adhesive Substances 0.000 description 19
- 241000193830 Bacillus <bacterium> Species 0.000 description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 18
- 230000001070 adhesive effect Effects 0.000 description 18
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 18
- 230000036541 health Effects 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 206010011224 Cough Diseases 0.000 description 17
- 235000013305 food Nutrition 0.000 description 17
- 210000002216 heart Anatomy 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 150000008442 polyphenolic compounds Chemical class 0.000 description 16
- 235000013824 polyphenols Nutrition 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 230000003203 everyday effect Effects 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 239000000341 volatile oil Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 230000008485 antagonism Effects 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 244000061520 Angelica archangelica Species 0.000 description 12
- 229920000858 Cyclodextrin Polymers 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 241000191967 Staphylococcus aureus Species 0.000 description 11
- 206010047700 Vomiting Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 11
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 230000005855 radiation Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000006378 damage Effects 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- 230000028327 secretion Effects 0.000 description 10
- 230000008673 vomiting Effects 0.000 description 10
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 9
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 9
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 229960001948 caffeine Drugs 0.000 description 9
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 208000014674 injury Diseases 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 229910052742 iron Inorganic materials 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 8
- 229920000945 Amylopectin Polymers 0.000 description 8
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 229940074393 chlorogenic acid Drugs 0.000 description 8
- 235000001368 chlorogenic acid Nutrition 0.000 description 8
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 8
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 8
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 8
- 150000001875 compounds Chemical group 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 230000000242 pagocytic effect Effects 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 8
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 8
- 241000432824 Asparagus densiflorus Species 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 7
- 208000037386 Typhoid Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 239000003085 diluting agent Substances 0.000 description 7
- 239000007884 disintegrant Substances 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 239000003292 glue Substances 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 201000008297 typhoid fever Diseases 0.000 description 7
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 6
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 206010006451 bronchitis Diseases 0.000 description 6
- 210000004413 cardiac myocyte Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000035900 sweating Effects 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 5
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 229920000856 Amylose Polymers 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 5
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 5
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 5
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000001077 hypotensive effect Effects 0.000 description 5
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 5
- 239000002932 luster Substances 0.000 description 5
- 229940041616 menthol Drugs 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 239000003182 parenteral nutrition solution Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000006072 paste Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000003449 preventive effect Effects 0.000 description 5
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 5
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 5
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 5
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- GMBQZIIUCVWOCD-UQHLGXRBSA-N (25R)-5beta-spirostan-3beta-ol Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 GMBQZIIUCVWOCD-UQHLGXRBSA-N 0.000 description 4
- HEVGGTGPGPKZHF-UHFFFAOYSA-N 1-(1,2-dimethyl-3-methylidenecyclopentyl)-4-methylbenzene Chemical compound CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 206010006458 Bronchitis chronic Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- HSSJYSJXBOCKQM-GVTGEURHSA-N Methylprotodioscin Chemical compound C([C@H](C)CC[C@]1(OC)[C@H]([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@@H](CC5=CC[C@H]4[C@@H]3C[C@@H]2O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HSSJYSJXBOCKQM-GVTGEURHSA-N 0.000 description 4
- 241000192041 Micrococcus Species 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 240000007711 Peperomia pellucida Species 0.000 description 4
- 102100038567 Properdin Human genes 0.000 description 4
- 108010005642 Properdin Proteins 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000607764 Shigella dysenteriae Species 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- WQLVFSAGQJTQCK-CAKNJAFZSA-N Yamogenin Chemical group O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 WQLVFSAGQJTQCK-CAKNJAFZSA-N 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 229940076810 beta sitosterol Drugs 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000003727 cerebral blood flow Effects 0.000 description 4
- 208000007451 chronic bronchitis Diseases 0.000 description 4
- 238000010411 cooking Methods 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000017574 dry cough Diseases 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- 229960004232 linoleic acid Drugs 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229940007046 shigella dysenteriae Drugs 0.000 description 4
- 229950005143 sitosterol Drugs 0.000 description 4
- HPPWMWCITPGPKK-UHFFFAOYSA-M sodium;1-hydroxy-3-oxododecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCC(=O)CC(O)S([O-])(=O)=O HPPWMWCITPGPKK-UHFFFAOYSA-M 0.000 description 4
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 235000017060 Arachis glabrata Nutrition 0.000 description 3
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 description 3
- 235000018262 Arachis monticola Nutrition 0.000 description 3
- 244000080767 Areca catechu Species 0.000 description 3
- 235000006226 Areca catechu Nutrition 0.000 description 3
- 241000432767 Asparagus setaceus Species 0.000 description 3
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 3
- 241000345998 Calamus manan Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000201295 Euphrasia Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010019345 Heat stroke Diseases 0.000 description 3
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 3
- 241000589902 Leptospira Species 0.000 description 3
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- 241000405414 Rehmannia Species 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 206010039424 Salivary hypersecretion Diseases 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000002790 anti-mutagenic effect Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 230000002057 chronotropic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 229940099112 cornstarch Drugs 0.000 description 3
- WTYGAUXICFETTC-UHFFFAOYSA-N cyclobarbital Chemical compound C=1CCCCC=1C1(CC)C(=O)NC(=O)NC1=O WTYGAUXICFETTC-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 230000003212 lipotrophic effect Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 150000002729 menthone derivatives Chemical class 0.000 description 3
- 229960001252 methamphetamine Drugs 0.000 description 3
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 3
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000003507 refrigerant Substances 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 208000026451 salivation Diseases 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000008925 spontaneous activity Effects 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- VEAUNWQYYMXIRB-XSHSDMCLSA-N (+)-nyasol Chemical compound C1=CC(O)=CC=C1\C=C/[C@H](C=C)C1=CC=C(O)C=C1 VEAUNWQYYMXIRB-XSHSDMCLSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZNDCJNWMQMVSQG-UHFFFAOYSA-N 3-(2-morpholin-4-ylethylamino)propanenitrile Chemical compound N#CCCNCCN1CCOCC1 ZNDCJNWMQMVSQG-UHFFFAOYSA-N 0.000 description 2
- ASHVULSQMDWKFO-UHFFFAOYSA-N 5-(methoxymethyl)furan-2-carbaldehyde Chemical compound COCC1=CC=C(C=O)O1 ASHVULSQMDWKFO-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 2
- 241001412627 Adenophora liliifolia Species 0.000 description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 2
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 241000255601 Drosophila melanogaster Species 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000710188 Encephalomyocarditis virus Species 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000175212 Herpesvirales Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241000218195 Lauraceae Species 0.000 description 2
- 241001215120 Leptospirales Species 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- MDCUMTGKKLOMCW-XNVNDPJESA-N Pseudoprotodioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)C(C)=C(O5)CC[C@@H](C)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O MDCUMTGKKLOMCW-XNVNDPJESA-N 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- PZZRDJXEMZMZFD-ODPGBAFUSA-N Reynoutrin Natural products O[C@H]1[C@H](O)[C@@H](O)CO[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-ODPGBAFUSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- HSSJYSJXBOCKQM-UHFFFAOYSA-N Smilax saponin B Natural products O1C2CC3C4CC=C5CC(OC6C(C(O)C(OC7C(C(O)C(O)C(C)O7)O)C(CO)O6)OC6C(C(O)C(O)C(C)O6)O)CCC5(C)C4CCC3(C)C2C(C)C1(OC)CCC(C)COC1OC(CO)C(O)C(O)C1O HSSJYSJXBOCKQM-UHFFFAOYSA-N 0.000 description 2
- 241001149962 Sporothrix Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241001279009 Strychnos toxifera Species 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 206010043189 Telangiectasia Diseases 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- UOSAURRLFAZAEE-UHFFFAOYSA-N acetic acid 2-(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)acetic acid Chemical compound CC(O)=O.C1CC2(C)C(CC(O)=O)CC1C2(C)C UOSAURRLFAZAEE-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical group OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000002026 carminative effect Effects 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 229940048961 cholinesterase Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ALRFYJWUVHBXLV-UHFFFAOYSA-N guaijaverin Natural products OC1COC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O ALRFYJWUVHBXLV-UHFFFAOYSA-N 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940089454 lauryl aldehyde Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000005360 mashing Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 239000004223 monosodium glutamate Substances 0.000 description 2
- 201000003152 motion sickness Diseases 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- HKZQJZIFODOLFR-UHFFFAOYSA-N piperitenone Chemical compound CC(C)=C1CCC(C)=CC1=O HKZQJZIFODOLFR-UHFFFAOYSA-N 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- MDCUMTGKKLOMCW-YNUPZFSTSA-N pseudo-protodioscin Natural products O(C[C@@H](CCC1=C(C)[C@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@H]4[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 MDCUMTGKKLOMCW-YNUPZFSTSA-N 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- PZZRDJXEMZMZFD-BWYUNELBSA-N quercetin-3-O-beta-D-xylopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-BWYUNELBSA-N 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 229950002323 smilagenin Drugs 0.000 description 2
- DXIHILNWDOYYCH-UHDJGPCESA-M sodium;(e)-3-phenylprop-2-enoate Chemical compound [Na+].[O-]C(=O)\C=C\C1=CC=CC=C1 DXIHILNWDOYYCH-UHDJGPCESA-M 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000009955 starching Methods 0.000 description 2
- 150000005856 steroid saponins Chemical class 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960005453 strychnine Drugs 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 208000009056 telangiectasis Diseases 0.000 description 2
- 208000014984 tetanic convulsion Diseases 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- HOZBSSWDEKVXNO-BXRBKJIMSA-N (2s)-2-azanylbutanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-BXRBKJIMSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 235000003930 Aegle marmelos Nutrition 0.000 description 1
- 244000058084 Aegle marmelos Species 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241001105170 Angelica anomala Species 0.000 description 1
- 208000000104 Arthus reaction Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- GOWMBOBXTOORFN-UHFFFAOYSA-N Asp-V Natural products O1C(CO)C(O)C(O)C(O)C1OCC(C)CCC(C(C1C2(C)CCC3C4(C)CC5)C)(O)OC1CC2C3CCC4CC5OC(C(C(O)C1O)O)OC1COC1OC(C)C(O)C(O)C1O GOWMBOBXTOORFN-UHFFFAOYSA-N 0.000 description 1
- YINDMVKVAWOMNC-UHFFFAOYSA-N Asp-VI Natural products COC1(CCC(C)COC2OC(CO)C(O)C(O)C2O)OC3CC4C5CCC6CC(CCC6(C)C5CCC4(C)C3C1C)OC7OC(COC8OC(C)C(O)C(O)C8O)C(OC9OCC(O)C(O)C9O)C(O)C7O YINDMVKVAWOMNC-UHFFFAOYSA-N 0.000 description 1
- GIZZBNSMEBLASA-UHFFFAOYSA-N Asp-VII Natural products O1C2CC3C4CCC5CC(OC6C(C(O)C(OC7C(C(O)C(O)CO7)O)C(COC7C(C(O)C(O)C(C)O7)O)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CCC3(C)C2C(C)C1(OC)CCC(C)COC1OC(CO)C(O)C(O)C1O GIZZBNSMEBLASA-UHFFFAOYSA-N 0.000 description 1
- 241000234427 Asparagus Species 0.000 description 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 description 1
- 244000248539 Asparagus cochinchinensis Species 0.000 description 1
- 241000432811 Asparagus racemosus Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- BEXOCDZQUVWNBD-UHFFFAOYSA-N C(CCCCCCCCC)(=O)O.C(C)=O Chemical compound C(CCCCCCCCC)(=O)O.C(C)=O BEXOCDZQUVWNBD-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 206010011686 Cutaneous vasculitis Diseases 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241001113556 Elodea Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 241000935235 Fritillaria meleagris Species 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000270288 Gekko Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000758769 Houttuynia Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 206010024214 Lenticular opacities Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 241001299895 Microsporum ferrugineum Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- VEAUNWQYYMXIRB-UHFFFAOYSA-N Nyasol Natural products C1=CC(O)=CC=C1C=CC(C=C)C1=CC=C(O)C=C1 VEAUNWQYYMXIRB-UHFFFAOYSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- VATCAOIQZROKKT-UHFFFAOYSA-L S(=O)([O-])S(=O)[O-].[Na+].C(CCCCCCCCC)(=O)CC=O.[Na+] Chemical compound S(=O)([O-])S(=O)[O-].[Na+].C(CCCCCCCCC)(=O)CC=O.[Na+] VATCAOIQZROKKT-UHFFFAOYSA-L 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- CIOAGBVUUVVLOB-NJFSPNSNSA-N Strontium-90 Chemical compound [90Sr] CIOAGBVUUVVLOB-NJFSPNSNSA-N 0.000 description 1
- 235000016641 Syzygium paniculatum Nutrition 0.000 description 1
- 244000223082 Syzygium paniculatum Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000396377 Tranes Species 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- SOSLMHZOJATCCP-AEIZVZFYSA-N afzelin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O SOSLMHZOJATCCP-AEIZVZFYSA-N 0.000 description 1
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000469 anti-sperm effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000013605 boiled eggs Nutrition 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229960005004 cholera vaccine Drugs 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000004939 coking Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000024389 cytopenia Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 239000008862 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000009431 guipi Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- SEZLYIWMVRUIKT-UHFFFAOYSA-N isopiperitenone Natural products CC(=C)C1CCC(C)=CC1=O SEZLYIWMVRUIKT-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001730 monoaminergic effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940031348 multivalent vaccine Drugs 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000002040 neurosyphilis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- KRFBMPVGAYGGJE-UHFFFAOYSA-N nevadensin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(O)C(OC)=C2O1 KRFBMPVGAYGGJE-UHFFFAOYSA-N 0.000 description 1
- FRZBKSSGEGEIAN-UHFFFAOYSA-N nevadensin Natural products COc1cccc(c1)-c1cc(=O)c2c(O)c(OC)c(O)c(OC)c2o1 FRZBKSSGEGEIAN-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 210000000826 nictitating membrane Anatomy 0.000 description 1
- YUPOCHDBBHTUBJ-UHFFFAOYSA-N nonadecan-10-one Chemical compound CCCCCCCCCC(=O)CCCCCCCCC YUPOCHDBBHTUBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003169 respiratory stimulant agent Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明主要涉及可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,其特点是包括有如下重量份的原料:白芷提取物10-30重量份、金银花提取物10-30重量份、枸杞子提取物10-30重量份、薄荷提取物10-30重量份、龙眼肉提取物10-30重量份、天门冬提取物10-30重量份、糊精300-400重量份、麦门冬提取物10-30重量份、肉桂提取物10-20重量份、生姜提取物10-20重量份、淀粉300-400重量份、白砂糖10-20重量份、绿茶提取物10-100重量份、鱼腥草提取物10-30重量份;本发明以传统中医药理论为指导,精心选料,严谨组方。方中白芷消肿止痛;金银花抗炎;枸杞子调节血脂和血糖;鱼腥草抗病毒;肉桂活血通经;生姜发汗解表;糊精可提高浆液的浸透性。组方从整体上改善身体状况,增强免疫力、抗病原微生物、抗病毒。
Description
技术领域:
本发明主要涉及可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法。
背景技术:
目前,可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂的配方,已有相关报道。大多以单一成份为原料,有些过分追求药物的保健功能而忽略茶饮料的本质特点要求。本配方弥补了现有配方之不足:
1、本发明以复方形式组成较大的配方,追求传统中医理论的整体理疗作用、使凉热平衡,不使保健功能偏热或偏凉,常服对人体有利无弊。方中原料皆为药食同源的天然植物,并取其精华(提取物),摒弃糟粕植物木质素、纤维素。选料时既追求功效,又注重茶饮料的适口性和色香味,使产品更具魅力;不选择苦味重、异味大的原料,使产品显著的同时,更加美味可口,最大限度地保留茶饮料的本质特点和口感要求。
2、本配方既追求改善免疫功能,有考虑抗菌、抗病毒。还追求适口性,一举多得。
发明内容:
本发明的目的在于避免现有技术的不足之处而提供一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法,以解决现有技术存在的问题。
本发明的目的可通过采用以下技术方案来实现:一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,其主要特点是包括有如下重量份的原料:白芷提取物10-30重量份、金银花提取物10-30重量份、枸杞子提取物10-30重量份、薄荷提取物10-30重量份、龙眼肉提取物10-30重量份;
所述的可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,还包括有如下重量份的原料:天门冬提取物10-30重量份、麦门冬提取物10-30重量份、肉桂提取物10-20重量份、生姜提取物10-20重量份、糊精300-400重量份;
所述的可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,还包括有如下重量份的原料:淀粉300-400重量份、白砂糖10-20重量份、绿茶提取物10-100重量份、鱼腥草提取物10-30重量份;
一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂的制备方法,其主要特点在于,包括如下步骤:
(1)原料制备
将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶分别进行精选,漂洗两次,淋去水分;在温度为60~80℃烘干1.5-2小时,使其水分为5-6%,粗粉碎后粒度为5-50mm加水是物料的8倍,浸提2-8小时,提取2次;将两次过滤液合并,浓缩,在温度为60-80℃烘干1.5-2小时,使其含水分为5-6%;粉碎、过筛,粒度为0.1-0.5mm,为中药提取物细粉。
(2)将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶等提取物和糊精、淀粉、白砂糖按比例混合均匀后,干燥、整粒、过筛;
(3)过筛后按每袋5-10克装袋;
(4)灭菌装箱。
一、本发明的有益效果是:我们使用科学先进的方法筛选原料、严谨组方,经过各种原料及其化学成份、功能作用的检验,现汇总本发明的分析结果如下:
(1)白芷:
祛风,燥湿,消肿,止痛。治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣。
白芷的作用:
1、白芷对中枢神经系统有兴奋作用:小量白芷毒素对动物延髓血管运动中枢、呼吸中枢、迷走神经及脊髓均有兴奋作用,能使血压上升,
脉搏变慢,呼吸加深,并能引起流涎呕吐;大量应用能引起强直间歇性痉挛,继而全身麻痹。
2、白芷有抗炎、抗菌作用:川白芷水煎剂对各种均有一定抑制作用,对L型结核有显著的抑制作用。白芷在试管内对絮状表皮癣菌、石膏样子芽孢癣菌等真菌有抑制作用,水浸剂(1∶3)对奥杜盎氏子芽孢癣菌也有一定的抑制作用。
3、白芷有降血压作用:其所含异欧前胡素和印度榅桲对猫有降血压作用,作用时间维持1.5小时。
4、白芷有光敏作用:其所含的香柑内酯、花椒毒素、异欧前胡素等呋喃香豆素类化合物为“光活性物质”,可用于治疗白癜风。
白术的生理功能:
1、保护胃黏膜。白术挥发油、丙酮提取物及苍术酮单体均能保护胃黏膜,抑制大鼠应激性胃溃疡、盐酸-乙醇溃疡及幽门结扎溃疡。
2、保护肝脏。煎剂或苍术酮给小鼠灌胃,对CC14肝损伤有保护作用,可防止肝糖原减少,病理切片可见肝组织脂肪浸润减轻,肿大和坏死减少。
3、抗癌作用。用白术挥发油进行腹腔注射,对小鼠艾氏腹水癌、淋巴肉癌腹水型及人109食管癌均有显著抑制作用。白术挥发油(500ug/ml)、苍术酮(50ug/ml)、白术内酯B(100ug/ml)与人109食管癌细胞接触24~48h后,可使细胞脱落,核固缩,染色体浓缩,细胞不分裂或极少分裂,表现均有抑制作用。
(2)金银花:
金银花,又名银花、金花、忍冬花、金藤花等。每当夏秋季来临,我国南北诸省的山区、丘陵,都有这种蔓藤爬攀植物,开黄白两色的鲜花,清香扑鼻,这就是“金银花”。花开时初为纯白,继而变黄,十分好看。采集该花颇有讲究,须在晴天清晨露水刚干时摘取,并及时晾晒或阴干,这样药效才佳。
金银花的作用:
1>.抗病原微生物作用:体外实验表明,花和藤对多种致病菌如金黄色葡萄球菌、溶血性链球菌、大肠杆菌、痢疾杆菌、霍乱弧菌、伤寒杆菌、副伤寒杆菌等均有一定抑制作用,对肺炎球菌、脑膜炎双球菌、绿脓杆菌,结核杆菌亦有效。水浸剂比煎剂作用强,叶煎剂比花煎剂作用强。若和连翘合用,抗菌范围还可互补;与青霉素合用,能加强青霉素对耐药金黄色葡萄球菌的抗菌作用,这可能是在抑制细菌体内蛋白质合成上有协同的作用。有人认为绿原酸和异绿原酸是金银花主要的抗菌有效成分。
2>.抗炎和解热作用:腹腔注射金银花提取液0.25g/kg,能抑制大鼠角叉菜胶性脚肿。另有报道金银花注射液30-40g/kg能减轻蛋清性脚肿程度。腹腔注射金银花提取液8g/kg,2次/天,连续6天,对大鼠巴豆油性肉芽囊,也有明显抗渗出和抗增生的作用。早期报道金银花具有明显的解热作用,但用霍乱菌苗、 马铃薯杆菌、枯草浸液等给家兔耳静脉注射,致热,未证实金银花煎剂5g/kg灌胃有退热作用,认为这可能和使用的金银花制剂、剂量或家兔的耐受性不同有关。
3>.免疫调节,加强防御机能作用:金银花煎剂稀释至1∶1280的浓度,仍能促进白细胞的吞噬功能。小鼠腹腔注射金银花注射液,也有明显促进炎性细胞吞噬功能的作用。
4>.中枢兴奋作用:经电休克、转笼等多种实验方法证明口服绿原酸后,可引起大鼠、小鼠等动物中枢神经系统兴奋,其作用强度为咖啡因的1/6,二者合用无相加及增强作用。
5>.降血脂作用:大鼠灌胃金银花2.5g/kg能减少肠内胆固醇吸收,降低血浆中胆固醇含量。体外实验也发现金银花可和胆固醇相结合,但四妙勇安汤(金银花、玄参、当归、甘草)治疗家兔实验性动脉粥样硬化。未观察到有降血脂和主动脉壁胆固醇含量的作用。
6>.抗内毒素:用鲎试验法测定内毒素含量,300%金银花(忍冬)注射液以1∶2-1∶64稀释,体外试验无论用凹片法或试管法,均明显降低试液中的内毒素含量,其中1∶2-1∶8的稀释管与阴性对照管一样呈液态,阳性对照呈凝胶状。金银花(忍冬)蒸馏液6g/kg静脉注射,对绿脓杆菌内毒互2.8mg/kg静脉注射引起的兔体温下降及白细胞数下降有对抗作用,金银花(忍冬)蒸馏液7.5g/kg或注射液2.5g/kg腹腔注射,对绿脓杆菌内毒素65mg/kg腹腔注射的小鼠有保护作用,减少小鼠死亡率。
7>.其它作用:曾有体外筛选实验报告金银花的水及酒浸液对肉瘤180及艾氏腹水癌有明显的细胞毒作用。金银花提取物口服对大鼠实验性胃溃疡有轻度预防效果。口服大剂量绿原酸能增加胃肠蠕动,促进胃液及胆汁分泌。绿原酸及其分解产物对大鼠离体子宫有兴奋作用。此外,绿原酸还能轻微增强肾上腺素及其去甲肾上腺素对猫和大鼠的升压作用,但对猫的瞬膜反应无影响。
(3)枸杞子:
为茄科植物宁夏枸杞Lycium barbarum L.的干燥成熟果实。其味甘、性平具有补肝益肾之功效,《本草纲目》中说“久服坚筋骨,轻身不老,耐寒暑。”补肾益精,养肝明目,补血安神,生津止渴,润肺止咳。治肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精。
中医常用它来治疗肝肾阴亏、腰膝酸软、头晕、健忘、目眩、目昏多泪、消渴、遗精等病症。现代药理学研究证实枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用,并应用于临床。枸杞子服用方便,可入药、嚼服、泡酒。但外邪实热,脾虚有湿及泄泻者忌服。
枸杞子的作用:
1.抗脂肪肝的作用:宁夏枸杞子的水浸液(20%,8毫升/天灌胃),对由四氯化碳毒害的小鼠,有轻度抑制脂肪在肝细胞内沉积、促进肝细胞新生的作用。水提取物的抗脂肪肝的作用还表现在,防止四氯化碳引起的肝功能紊乱(以胆碱酯酶、转氨酶的活性作指标)。如给大鼠较长期(75天)口服枸杞水提取物或甜菜碱,可升高血及肝中的磷脂水平;受四氯化碳毒害后之大鼠,肝中磷脂、总胆甾醇含量减低,事先或同时给甜菜碱或枸杞水提取物则有所升高;同时对BSP、SGPT、碱性磷酸酶、胆碱酯酶等试验均有改善作用。枸杞对脂质代谢或抗脂肪肝的作用,主要是由于其中所含的甜菜碱所引起,后者在体内起甲基供应体的作用。
2.拟胆碱样作用:枸杞的水提取物静脉注射,可引起兔血压降低,呼吸兴奋;阿托品或切断迷走神经可抑制此反应。它还能抑制离体兔心耳、兴奋离体肠管(在离体豚鼠小肠上,8毫克≌组胺1微克,其作用可被苯海拉明或阿托品所阻断)、收缩兔耳血管等。甜菜碱无此作用,对兔耳血管则为扩张作用。甲醇、丙酮、乙酸乙酯等提取物亦有轻度降压作用。故枸杞的上述作用为甜菜碱以外的成分所引起。
生理功能:
1、增强免疫力:小鼠灌服水提取物(100%,0.4ml/d×3d)或肌注醇提物(100%,0.1ml),均能显著增强其网状内皮系统对印度墨汁的吞噬能力。水提取物或枸杞多糖均能促进小鼠腹腔巨噬细胞的吞噬功能和血清中溶菌酶活力。给正常或老年小鼠灌服或腹注枸杞多糖7d,能显著增强腹腔巨噬细胞C3b和Fc的受体数和活力。可使老年小鼠抑制性T细胞调节抗体功能恢复到成年小鼠的水平。枸杞多糖纯品10mg/kg×7d,比粗品有更显著的免疫应答效应,各项免疫指标(包括菲特异免疫的免疫器官质量、巨噬细胞吞噬作用、特异性体液免疫的血清溶血素、特异性细胞免疫中的迟发型变态反应、淋巴细胞软化率、E玫瑰花结形成等)均有极显著差异。有报道对艾滋病人免疫指标人体中P-24抗体有升高作用。
2、枸杞抗衰老作用:目前衰老学说有:中毒学说、伤害学说、免疫学说、内分泌功能减退学说、自由基学说、交联学说、细胞结构变化和蛋白质变性学说、遗传学说等,其中自由基学说一直占有重要的地位。衰老的自由基理论是1965年由Harman D提出的。该理论认为衰老是来自机体正常代谢过程中产生的自由基引起不饱和脂肪酸氧化成超氧化物,形成脂褐素,破坏细胞膜及其它重要成分,使蛋白质和酶变性,从而加速衰老。同时,机体内存在各种自由基清除剂(也叫抗氧化剂)起清除自由基的作用。两者处于动态平衡,当自由基产生的过多或抗氧化剂过少时就会引起衰老。
脂褐素和过氧化脂质水平的高低反映细胞内脂质过氧化损伤的两个重要指标。在这两个指标的基础上,徐承水采用枸杞水提取液对美国野生型黑腹果蝇(Drosophila Milanogdeter)进行实验。分为寿命实验组,脂褐素实验组和过氧化脂质试验组,三者均设对照。通过寿命统计得出,饲喂添加Lc Me饲料的果蝇,其唾腺细胞中的脂褐素和过氧化脂质水平均显著降低,这说明Lc Me能抑制活性氧的产生,降低细胞膜不饱和脂酸的脂质过氧化作用,从而拮抗细胞的过氧化损伤,对细胞起保护作用。
3、降血糖、降血脂:Qiong Luo等人通过用枸杞水煎剂、枸杞粗多糖提取物及纯化的枸杞多糖对四氧嘧啶糖尿病或高血脂大白兔分别进行连续灌喂,发现这3种枸杞提取物能显著降低血糖及血总胆固醇(TC)和甘油三酯(TG)浓度,同时在显著提高高密度脂蛋白胆固醇(HDL-C)水平后,通过10d的灌喂,都显示有较强的降血糖和降血脂作用。并发现纯化的枸杞多糖在降血糖作用方面显著高于水煎剂和粗枸杞,但其降血脂作用似乎较弱。
4、抗突变:李伯灵等人采用微核试验、Ames试验和DNA修复试验方法评价不同浓度的枸杞粗糖的抗突变作用。发现加入不同浓度的枸杞多糖粗品(LBPc)后,其抗突变作用由弱变强,得出LBPc具有明显的抗突变作用。
枸札水撮物有降压、抑制心脏、兴奋肠道等拟碱作用。枸杞水抽提液可加快兔离体子宫的收缩频率和增加其张力。此外,枸杞提取物还能促进乳酸菌的生长及产酸。
5、枸杞抗衰老作用:目前衰老学说有:中毒学说、伤害学说、免疫学说、内分泌功能减退学说、自由基学说、交联学说、细胞结构变化和蛋白质变性学说、遗传学说等, 其中自由基学说一直占有重要的地位。衰老的自由基理论是1965年由Harman D提出的。该理论认为衰老是来自机体正常代谢过程中产生的自由基引起不饱和脂肪酸氧化成超氧化物,形成脂褐素,破坏细胞膜及其它重要成分,使蛋白质和酶变性,从而加速衰老。同时,机体内存在各种自由基清除剂(也叫抗氧化剂)起清除自由基的作用。两者处于动态平衡,当自由基产生的过多或抗氧化剂过少时就会引起衰老。脂褐素和过氧化脂质水平的高低反映细胞内脂质过氧化损伤的两个重要指标。在这两个指标的基础上,徐承水采用枸杞水提取液对美国野生型黑腹果蝇(Drosophila Milanogdeter)进行实验。分为寿命实验组,脂褐素实验组和过氧化脂质试验组,三者均设对照。通过寿命统计得出,饲喂添加Lc Me饲料的果蝇,其唾腺细胞中的脂褐素和过氧化脂质水平均显著降低,这说明Lc Me能抑制活性氧的产生,降低细胞膜不饱和脂酸的脂质过氧化作用,从而拮抗细胞的过氧化损伤,对细胞起保护作用。
其副作用:
枸杞虽然具有很好的滋补和治疗作用,但也不是所有的人都适合服用的。由于它温热身体的效果相当强,正在感冒发烧、身体有炎症、腹泻的人最好别吃。最适合吃枸杞的是体质虚弱、抵抗力差的人。而且,一定要长期坚持,每天吃一点,才能见效。
不是所有的人都适合服用的。由于它温热身体的效果相当强,正在感冒发烧、身体有炎症、腹泻的人最好别吃。①由于枸杞温热身体的效果相当强,患有高血压、性情太过急躁的人,或平日大量摄取肉类导致面泛红光的最好不要食用;②枸杞子可滋补肝肾,但肝肾不虚也就没有必要服;③它毕竟是药品,药品治疗疾病是靠其偏性,也就是我们常说的药性。补阴药也为虚证而设,凡身体健康无虚证者,不宜应用,邪实而正气不虚者,不宜乱用补虚药,以防“闭门留寇”;④虚寒的人服用会有滑脱泄泻之弊,有内热未清慎用;⑤有的人枸杞子吃太多造成眼睛红红胀胀不舒服,视力模糊。所以说,枸杞子不可常吃,是药三分毒。
(4)薄荷:
薄荷主要含荨荷脑、薄荷酮等挥发油成分。
1、薄荷脑薄荷挥发油.主要为薄荷脑.占62%,又称薄荷醇。
2、薄荷酮挥发油中薄荷酮占15%,异薄荷酮占6%。
3、其他挥发油尚含薄荷烯酮、莰烯、蒎烯、桂叶烯、柠檬烯、薄荷烷、薄荷酯类、儿茶萘酚酸、蓝香油烃等。
薄荷的作用:
薄荷「主贼风伤寒,发汗,治恶气心腹胀痛。」;中医也认为薄荷「性凉味辛,有宣散风热、清头目、透疹之功」,知其具有兴奋大脑、促进血液循环、发汗,与消炎鎭痛、止痒解毒和疏散风热的作用。
药理作用:
1、局部作用:薄荷水局部应用有清凉、止痒、消炎、止痛的功效。薄荷醇能刺激皮肤神经末梢感受器,先产生凉的感觉,继而有轻微的灼热感。缓慢地透人皮内,引起长时间的充血,而达到治疗作用。
2、解热:小量薄荷能兴奋中枢神经,使周围毛细血管扩张而散热;并促进汗腺分泌而发汗。因此有降低体温的作用。
3、抗炎:薄荷所含的8种儿茶萘酚酸是有效的抗炎剂,能抑制3a一羟类固醇脱氢酶而有弱自:抗炎作用。薄荷所含的蓝香油烃对烫伤兔耳有抗炎作用。
4、薄荷能增加呼吸道黏液的分泌。祛除了附着于黏膜上的黏液,能减少泡沫痰,使呼吸道的有效通气量增大。
5、薄荷油有健胃作用,对实验性胃溃疡有治疗作用;有较强的利胆作用,还有保肝作用。
6、薄荷油有抗精子着床、抗早孕的作用,其终止妊娠的原因,是由于能明显降低绒毛膜促性腺激素的水平,也可能与促进子宫收缩和损伤了胎盘有关。
临床应用:
1、治疗感冒、上呼吸道感染的发热、鼻塞、头痛、咽痛等症状。
2、治疗急慢性咽喉炎、扁桃体炎、鼻炎、球结膜炎。
3、治疗各种皮炎,如过敏性皮炎、虫咬性皮炎、荨麻疹、皮肤瘙痒症、银屑病、湿疹。
4、局部应用:薄荷醇的各种制剂,局部应用治疗头痛、牙痛和皮肤瘙痒。
薄荷的功效:
薄荷入茶饮,可以健胃祛风、祛痰、利胆、抗痉挛,改善感冒发烧、咽喉、肿痛,并消除头痛、牙痛、恶心感,及皮肤搔痒、腹部胀气、腹泻、消化不良、便秘丢等症状,且可缓和头痛,促进新陈代谢,对于呼吸道的发炎症状有治疗作用;还可降低血压、滋补心脏。其清凉香气,还可平缓紧张愤怒的情绪,能提振精神、使身心欢愉、帮助入眠。新鲜薄荷常用于制作料理或甜点,以去除鱼及羊肉腥味,或搭配水果及甜点,用以提味;也可做成消炎消肿的润肤水。
另外,可将生叶揉碎把汁液涂在虫咬、太阳穴、或及肌肉酸痛的部分,以达亸到止痒、止痛消肿,减轻酸痛的效果。乾薄荷则可用于泡澡,以缓和肩膀酸痛、神经痛;也能制成收敛水净化肌肤,或各式手工艺品。也因其有提神醒脑、舒缓肌肉及止痛的作用,所以也是制作各种药油、药膏不可或缺的重要成分、且薄荷也常被制成如香皂、牙膏及除臭剂等商品贩卖。因薄荷芳香辛散之故,所以肺虚咳嗽、阴虚发热多汗的患者也应慎用。
此外,薄荷的成分容易因受热而挥发失效,所以宜在水滚后再放入。而其具醒脑、兴奋的效果,故晚上不宜饮用过多,以免造成睡眠困扰。可与绿茶,红茶同泡,或直接用开水泡!
(5)龙眼肉:
龙眼肉,为无患子科植物龙眼的假种皮。俗称桂圆肉。性温,味甘。人心、脾经,益心脾,补气血,安神。主治气血不足,虚劳羸瘦,面色无华,神疲乏力,浮肿等;心血亏虚,心悸失眠、眼花,健忘易惊等。龙眼肉含有葡萄糖、酸类、腺瞟吟和胆碱,此外尚含有蛋白质和脂肪。
功能主治
补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。中医认为,龙眼味甘、性温。入心、脾经。具有补益心脾、养血宁神、健脾止泻、利尿消肿等功效。适用于病后体虚、血虚萎黄、气血不足、神经衰弱、心悸怔忡、健忘失眠等病症。早在汉朝时期,龙眼就己作为药用。李时珍说:“龙眼大补”,“食品以荔枝为贵,而资益则龙眼为良。”《日用本草》:“益智宁心。”《得配本草》认为:龙眼“益脾胃,葆心血,润五脏,治怔忡。”《泉州本草》认为:龙眼“壮阳益气,补脾胃。”《药品化义》)曰:“桂圆,大补阴血,凡上部失血之后,入归脾汤同莲肉、芡实以补脾阴,使脾旺统血归经。如神思劳倦,心经血少,以此助生地、麦冬补养心血。又筋骨过劳,肝脏空虚,以此佐熟地、当归,滋肝补血。”至今,龙眼仍然是一味补血安神的重要药物。
据现代研究,龙眼鲜食,味甜美爽口,且营养价值甚高,富含高碳水化合物、蛋白质、多种氨基酸和维生素B、C、钙、磷、铁、酒石酸、腺膘呤等,其中尤以含维生素P量多,对中老年人而言,有保护血管、防止血管硬化和脆性的作用。
国外在研究龙眼时发现其含有一种活性成分有抗衰老的作用。这与我国最早的药学专著《神农本草经》中所言龙眼有轻身不老之说相吻合。故此有人认为龙眼是具有较好开发潜质的抗衰老食品。
龙眼所含糖分量很高,为易消化吸收的单糖,可以被人体直接吸收,故体弱贫血,年老体衰,久病体虚,经常吃些龙眼是很有补益作用;妇女产后,龙眼也是重要的调补食品。因含铁及维生素B2很丰富,可以减轻子宫收缩及宫体下垂感。对于妇女产后、体虚乏力、贫血等,则可用龙眼肉加入当归、枸杞、红枣(去核)数颗炖鸡。或每日食用龙眼肉煮鸡蛋,可活血调经,促进体力恢复。
生理功能:
1、促进生长发育。用含龙眼肉1g/ml和蛤蚧0.5g/ml的提取液15ml/kg×14d给小鼠灌服,可使由利血平所致小鼠体重下降、活动减少等虚弱症状有明显好转。对正常小鼠灌服20ml/kg×6d,可增加体重,促进生长。
2、提高免疫力。给小鼠灌服龙眼肉-蛤蚧提取液20ml/kg×7d,能明显增加脾脏质量。154ml/kg×10d,可提高小鼠炭粒廓清指数。
理疗效果
1、益气补血,增强记忆:桂圆(龙眼干)含丰富的葡萄糖、蔗糖及蛋白质等,含铁量也较高,可在提高热能、补充营养的同时,又能促进血红蛋白再生以补血。实验研究发现,桂圆肉(龙眼干)除对全身有补益作用外,对脑细胞特别有益,能增强记忆,消除疲劳。
2、安神定志:桂圆(龙眼干)含有大量的铁、钾等元素,能促进血红蛋白的再生以治疗因贫血造成的心悸、心慌、失眠、健忘。桂圆(龙眼干)中含尼克酸高达2.5毫克(每100克),可用于治疗尼克酸缺乏造成的皮炎、腹泻、痴呆,甚至精神失常等。
3、养血安胎:桂圆(龙眼干)含铁及维生素比较多,可减轻宫缩及下垂感,对于加速代谢的孕妇及胎儿的发育有利,具有安胎作用。
4、抗菌,抑制癌细胞:动物实验表明,桂圆(龙眼干)对JTC-26肿瘤抑制率达90%以上,对癌细胞有一定的抑制作用。临床给癌症患者口服桂圆粗制浸膏,症状改善90%,延长寿命效果约80%。此外,桂圆(龙眼干)水浸剂(1∶2)在试管内对奥杜盎小芽孢癣菌有抑制作用。
5、降脂护心,延缓衰老:桂圆肉(龙眼干)可降血脂,增加冠状动脉血流量。对与衰老过程有密切关系的黄素蛋白——脑B型单胺氧化酶(MAO-B)有较强的抑制作用。
(6)天门冬:
中药天冬是百合科草本植物天冬的块根,天冬甘、苦,寒。具有滋阴、润肺、降火等功效,是秋冬滋补中药之一。天冬秋、冬采挖,洗净,除去根茎、须根,置沸水中蒸透心,除去外皮,干燥。可切片用。
天冬的功效与作用:
养阴生津、润肺清心、除燥降火。天冬具有镇咳、祛痰作用;对多种细菌有抑制作用;有抗肿瘤活性。天冬用于阴虚发热、肺燥干咳、虚劳咳嗽、津伤口渴、心烦失眠、内热消渴、肠燥便秘、肺痿、肺痈、白喉。
药理作用
1、抗菌作用:煎剂体外试验对炭疽杆菌、甲型及乙型溶血性链球菌、白喉杆菌、类白喉杆菌、肺炎双球菌、金黄色葡萄球菌、柠檬色葡萄球菌、白色葡萄球菌及枯草杆菌均有不同程度的抑菌作用。
2、杀灭蚊、蝇幼虫的作用:将切碎的根置水中使成0.5-1%浓度,可使其中的孑孓于72-96小时后全部死亡,2-5%浓度时,经3-4天,可使其中的蛆死亡70-100%。
3、抗肿瘤作用:体外试验(美蓝法及瓦氏呼吸器测定),天门冬对急性淋巴细胞型白血病、慢性粒细胞型白血病及急性单核细胞型白血病患者白细胞的脱氢酶有一定的抑制作用,并能抑制急性淋巴细胞型白血病患者白细胞的呼吸。印度产同属植物Asparagusracemosus中所含皂甙,对动物子宫有抗催产素的作用。
4、镇咳去痰作用:经动物试验有镇咳和去痰作用。
化学成分:
块根含甾体皂甙:天冬呋甾醇寡糖甙Asp-IV,Asp-V、Asp-VI、Asp-VII,甲基原薯蓣皂甙(methylprotodioscin),伪原薯蓣皂甙(pseudoprotodioscin),3-0(α-L-吡喃鼠李糖基(1→4)-β-D-吡喃葡萄糖基)-26-0-(β-D-吡喃葡萄糖基)-(25R)-5,20-呋甾二烯-3β,26二醇〔3-0-α-L-rhamnopyranosyl(1→4)-β-D-GLUCOPYRANOSYL-26-0-(β-D-glucopyranosyl)-(25R)-furosta-5,20-β,26-diol〕。近又从新鲜根茎分得6个甾体皂甙,其甙元为雅姆皂甙元(yamogenin),薯蓣皂甙元(diosgenin),菝葜皂甙元(sarsasapogenin),异菝葜皂甙元(smilagenin),糖部不含木糖(xylose),只含葡萄糖(glucose)和鼠李糖(rhamnose)。www.med126.com又含7个寡糖(oligosaccharide)I-VII,分别为含有葡萄糖和果糖(fructose)的三聚糖、四聚糖、五聚糖、六聚糖、八聚糖、九聚糖和十聚糖。还含葡萄糖,果糖,蔗糖(sucrose),5-甲氧基甲基糖醛(5-methoxymethyl furfural),β-谷甾醇(β-sitosterol)以及瓜氨酸(citrulline),天冬酰胺(asparagine),丝氨酸(serine),苏氨酸(threonine),脯氨酸(proline),甘氨酸(glycine),丙氨酸(alanine),缬氨酸(valine),蛋氨酸(methionine),亮氨酸(leucine),异亮氨酸(isoleucine),苯丙氨酸(phenylalanine),酷氨酸(tyrosine),天冬氨酸(aspartic acid),谷氨酸(glutamic acid),精氨酸(arginine),组氨酸(histidine),赖氨酸(lysine)等多种氨基酸。近从块根抑瘤有效部位中分离出4种多糖:天冬多糖(asparagus-polysaccharide)A、B、C、D。
目的对中药天门冬(Asparagus cochinchinensis(Lour.)Merr.)的化学成分进行研究。方法采用硅胶柱色谱、制备薄层色谱、重结晶等方法进行分离纯化,通过理化性质和核磁共振波谱数据鉴定化合物结构。结果分离得到8个化合物,分别鉴定为(+)-4′-0-methyl-nyasol(1)、(+)-nyasol(2)、5,7-二羟基-6,8,4′-三甲氧基黄酮(5,7-dihydroxyl-6,8,4′-t rimethoxylflavone,3)、菝葜皂苷元(sarsasapogenin,4)、5-羟甲基糠醛(5-hydroxymethylfuraldehyde,5)、β-谷甾醇(β-sitosterol,6)、胡萝卜苷(daucosterol,7)和豆甾醇(stigmasterol,8)。结论化合物3为首次从天门冬属中分离得到,化合物1、8为首次从该植物中分离得到。
(7)麦门冬:
养阴生津,润肺清心:用于肺燥干咳,虚痨咳嗽,津伤口渴,心烦失眠,内热消渴,肠燥便秘,咽白喉;养阴生津,润肺止咳:用于肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液等证。配沙参、川贝可治肺阴虚干咳。
麦冬的药理作用:
1、治疗暑天汗出虚脱用麦冬、人参各10克,五味子6克,水煎服,每日2剂。对汗出虚脱,心慌心悸,血压过低,汗多口渴,体倦乏力有良效(编者注:此方为金代名医李杲所创,方名叫“生脉散”,已制成生脉口服液)。
2、治疗肠燥便秘麦冬、生地、玄参各15克。水煎服,每日1剂。有润肠通便的作用,用于大便干燥。
3、治疗冠心病心绞痛麦冬45克,加水煎成30~40毫升,分次服用,连服3~18个月。对缓解心绞痛、胸闷均有一定作用。
4、治疗慢性胃炎麦冬、黄芪各9克,党参、玉竹、黄精各10克。水煎服,每日1剂,对胃阴不足者有良效。
5、治疗糖尿病用芦根30克,麦冬15克,知母12克。先用小火煎煮30分钟,滤出煎液,药渣再加水500毫升,大火煮开后改为小火煎煮20分钟,去渣取汁,将两次煎出的药汁混合,每日1剂。用于糖尿病患者口渴咽干、多饮、心烦不宁,或见低热,舌红,脉细数。
6、治疗急、慢性支气管炎麦冬、天冬、知母、川贝母、百部各9克,沙参12克。水煎服,每日1剂,本方适用于急、慢性支气管炎表现为阴虚燥咳者。
7、治疗慢性肝炎、早期肝硬化鸡蛋5个,枸杞、花生米、瘦猪肉各30克,麦冬10克,盐、湿淀粉、味精各适量。首先将花生米煎熟,枸杞洗净,入沸水中略氽一下。麦冬洗净,入沸水中煮熟,切成碎末,瘦猪肉切丁,鸡蛋打在碗内,加盐少许打匀,把蛋倒进另一碗中隔水蒸熟,冷却后将蛋切成粒状。锅置旺火上,放花生油,把肉丁炒熟,再倒进蛋粒、枸杞、麦冬碎末,炒匀,放盐少许及湿淀粉勾芡,放味精调味,铺上花生米即成。每日2次,佐餐食。具有滋补肝肾的作用,适用于慢性肝炎、早期肝硬化等的辅助治疗。健康人食用能增强体质,防病延年。
生理作用:
1、增强免疫力。
2、降血糖。兔灌服50%麦冬水浸液12.5g/kg,0.5~1小时内升高血糖作用达最高峰,5~6小时则逐渐降低,随后恢复到原来水平.给家兔肌肉注射100%麦冬煎剂(0.5g/kg),也有升高血糖作用。
3、对心血管系统的作用。麦冬注射液对蟾蜍、大鼠和兔离体或在位心脏及体外培养的乳鼠心肌细胞均有一定的抗心律失常、改善心肌缺血、增强心肌收缩力和减慢心率的作用.实验表明:麦冬注射液可显著减慢体外培养的大鼠乳鼠心肌细胞团的搏动频率,增加搏动强度,在一定范围内,麦冬的负性频率作用随剂量增加而增强,并能有效的对抗肾上腺素β受体激动剂异丙肾上腺素对心肌细胞团搏动的正性频率作用和诱发心律失常作用.该实验结果提示,麦冬对抗异丙肾上腺素的作用可能是通过阻断心肌细胞上的β受体实现的。有研究指出,β1受体与变时性效应有关,而β2受体则与正性肌力作用有关。据此可以认为心肌细胞团中可能含有β1与β2两种亚型受体的不同细胞,而麦冬对心肌细胞的负性频率作用,选择性地阻断异丙肾上腺素对心肌细胞的β1受体的正性变时性效应,提示麦冬注射液中可能含有选择性阻断肾上腺素β1受体的有效成分。
(8)鱼腥草:
鱼腥草为三白草科多年生草本植物蕺菜的干燥水上部分。产于我国长江流域以南各省。名见《名医别录》。唐苏颂说:″生湿地,山谷阴处亦能蔓生,叶如荞麦而肥,茎紫赤色,江左人好生食,关中谓之菹菜,叶有腥气,故俗称:鱼腥草。
化学成份:
地上部分含挥发油、内含抗菌有效成分癸酰乙醛(deCanoy acetaldehyde),月桂醛(lauric aldehyde),a-蒎烯(a-pinene)和芳樟醇(linlool),前两者并有特异臭气。还含甲基正壬基甲酮(methyL-n-nonylketone),樟烯(camphene),月桂烯(myrcene),柠檬烯(limonene),乙酸龙脑酯(bornyl acetate),丁香烯(caryophellene)。通常所说的鱼腥草素指的是癸酸乙醛的亚硫酸氢钠的加成物。另含阿福甙(afzelin),金丝桃甙(hy-perin),芸香甙(rutin),绿原酸(chlorogenicacid))以及β-谷甾醇(β-sitosterol),硬脂酸(stearic acid),油酸(oleic acid),亚油酸(linoleicacid)。叶含槲皮甙(qUercitrin),花和果穗含异槲皮甙(iso-quercitrin)。
主要成分:
全草含挥发油,其中有效成分为癸酰乙醛(即鱼腥草素,Decanoylacetaldehyde)、月桂醛(Lauraldehyde),2-十一烷酮(2-Undecano-ne),丁香烯(Caryophyllene),芳樟醇(Linalool)、乙酸龙脑酯(Bornyl acetate),α-蒎烯(α-Pinene)、莰烯(Camphene)、月桂烯(Myrcene)和d-柠檬烯(d-Limonene)、甲基正壬基酮(Methyl-n-nonyl-ketone)、癸醛(Capric aldehyde)、癸酸(Capricacid)。花、叶、果中均含有槲皮素(Quercetin)、槲皮甙(Quercitrin)、异槲皮甙(Isoquercitrin)、瑞诺甙(Reynoutrin)、金丝桃甙(Hyperin)、阿夫甙(Afzerin)、芸香甙(Rutin)。尚含有绿原酸(Chlorogenic)、棕榈酸(Palmitic)、亚油酸(Linoleic acid)、油酸(Olei acid);氯化钾、硫酸钾。以及β-谷甾醇(β-Sitosterol)和蕺菜碱(Cordarine).
药理作用
1、提高机体的免疫力:鱼腥草可以增强WBC的吞噬能力,提高血清备解素,在治疗慢性气管炎时,合成鱼腥草素可使患者WBC对白色葡萄球菌的吞噬能力明显提高,血清备解素明显升高。家兔每日肌肉注射鱼腥草素8mg。连续给药3天后,血清中备解素也明显升高,鱼腥草提高机体免疫力,对感染性病的治疗有着重要的意义。
2、抗菌的作用:鱼腥草中提得一种黄色油状物,对各种微生物(尤其是酵母菌和霉菌)均有抑制作用,对溶血性的链球菌、金黄色葡萄球菌、流感杆菌、卡他球菌、肺炎球菌有明显的抑制作用。对大肠杆菌、痢疾杆菌、伤寒杆菌也有作用,人工合成的癸酰乙醛亚硫酸氢钠加成物称为合成的鱼腥草素。合成的十二酰乙醛亚硫酸氢钠加成物称为新色腥草素,体内外实验对多种细菌均有较明显的抑制作用:对金黄色葡萄球菌及耐青霉素MIC为62.5-80mcg/ml,对流感杆菌为1.25mg/ml。普拜氏液体培养基上对结核杆菌H37RY株为16mcg/ml。在改良的苏通氏半固体培养基上则为25mcg/ml,其钾盐为12.5mcg/ml。合成的鱼腥草素异烟腙对TB杆菌有较强的作用,其MIC为0.78-3.1mcg/ml,对感染TB的小鼠。能明显的延长生存时间,每鼠1mg腹腔注射能使小鼠存活期延长62天,拌食喂饲疗效更好。
3、抗病毒作用:用人胚肾原代单层上皮细胞组织培养,鱼腥草煎剂(1∶10)对流感亚洲甲型京科68-1株有抑制作用,并能延缓孤儿病毒ECHOll的生长。朱宇同报道:用乙醇提取得到几个非挥发油部份。其中鱼腥草素III对流感病毒感染小鼠有预防性保护作用,对EMC和HSVII作用不明显,合成鱼腥草素的衍生物亦有较强的抗病毒作用。鱼腥草提取物(4g生药/ml)对复流感病毒感染的小鼠有明显预防保护作用。而对脑心肌炎病毒及疱疹病毒II型感染无明显保护作用。并证明鱼腥草抗流感病毒成分不在挥发油部分,而在非挥发物中。
4、利尿的作用:用鱼腥草提取物灌流蟾蜍肾或蛙蹼,能使毛细血管扩张,增加血流量及尿液分泌,从而具有利尿的作用。其作用可能由有机物所致,钾仅起增加利尿的附加作用,直接作用时,能使钩端螺旋体活动减弱-死亡-裂解,亦能推迟人工感染钩端螺旋体的豚鼠的发病期。
5、防辐射的作用:基础鱼腥草是惟一在原子弹爆炸点能顽强再生的中药材。鱼腥草具有抗辐射作用和增强机体免疫功能的作用,且无任何毒副作用,不仅适用于空勤人员,也适用于经常接近辐射源的人员,如X光机和电脑操作人员,以及常看电视的人群。电脑一族必吃的防辐射食物。
6、和TMP配伍作用的研究:张永恒报道,0.75mg/ml鱼腥草组和0.75mg/ml鱼腥草-7.5mg/mlTMP配伍组对比(t=5.6)P<0.001,有非常显着的差异性。0.75mg/ml鱼腥草素-7.5mg/mlTMP配伍组与7.5mg/mlTMP组对比(t=2.78)P<0.01,差异显着。说明二者合用的抑菌作用比单用为优,二者有协同作用。0.1ml/ml鱼腥草挥发油无抑菌作用,0.1ml/ml鱼腥草挥发油-7.5mg/mlTMP配伍组和7.5mg/mlTMP组对比(t=4.2)P<0.001,有极显着拮抗作用,说明鱼腥草挥发油能降低TMP的抑菌作用。但亦有例外,二者配伍能增强抗副伤寒及宋内氏痢疾杆菌的作用,故在肯定拮抗作用的同时,亦不应忽视对个别菌株有协同作用。
7、病原微生物作用:鱼腥草鲜汁对金黄色葡萄球菌有抑制作用,加热后作用减弱.体外试验证明,鱼腥草煎剂对多种革兰阳性细菌和阴性细菌如金黄色葡萄球菌、白色葡萄球菌、溶血性链球菌、肺炎双球菌、卡他球菌、白喉杆菌、变形杆菌、志贺、施氏、福氏及宋内痢疾杆菌、肠炎杆菌等均有不同程度的抑制作用.鱼腥草乙醚提取物在体外对结核杆菌有明显抑制作用.鱼腥草中提取得到的一种油状物,对各种微生物(尤其对霉菌和酵母)均有抑制作用,对溶血性链球菌、金黄色葡萄球菌、流感杆菌、卡他球菌、肺炎球菌有明显抑制作用;对大肠杆菌、痢疾杆菌、伤寒杆菌亦有抑制作用.但也有报道认为,鱼腥草煎剂抗菌作用不甚明显。
鱼腥草的主要抗菌有效成分癸酰乙醛对多种细菌、抗酸杆菌及真菌等均有较明显的抗菌作用,但该种化合物性质不稳定.其亚硫酸氢钠加成物则性质稳定而又保留其抗菌活性.我国人工合成的癸酰乙醛的亚硫酸氢钠加成物称为合成鱼腥草素,在体外对多种革兰阳性和阴性细菌都具有明显的抑菌作用,以金黄色葡萄球菌及其耐青霉素株、肺炎双球菌、甲型链球菌、流感杆菌较为敏感,卡他球菌、伤寒杆菌次之,而大肠杆菌、绿脓杆菌及痢疾杆菌不甚敏感.对于小鼠的结核菌感染,鱼腥草素能明显延长其生存时间.另外,对白色念珠菌、新型隐球菌、孢子丝菌、曲菌、着色霉菌、红色癣菌、叠瓦癣菌、石膏样小孢子菌、铁锈色小孢子菌、鲨癣菌等亦有明显抑制作用.人工合成的十二酰乙醛亚硫酸氢钠加成物则称为新鱼腥草素,在体外对肺炎双球菌、伤寒杆菌、金黄色葡萄球菌、大肠杆菌及孢子丝菌等也有抑制作用.合成崐的鱼腥草素异烟腙在体外及体内对结核杆菌均有较强的抑制作用。
鱼腥草煎剂在试管内对钩端螺旋体有较强的抑制作用.直接作用时,能使钩端螺旋体活动减弱-死亡-裂解,并能推迟人工感染钩端螺旋体的豚鼠的发病期。
用人胚肾原代单层上皮细胞组织培养,鱼腥草煎剂(1∶10)对流感亚洲甲型京科68-1株有抑制作用,并能延缓孤儿病毒(ECHO11)的生长.实验证明:鱼腥草抗流感病毒成分在非挥发物中.鱼腥草提取物对流感病毒感染的小鼠有明显预防保护作用,用灌胃和滴鼻给药途径均有明显效果;但对脑心肌炎病毒及疱疹病毒II型感染无明显保护作用。
8、对免疫系统的作用:鱼腥草煎剂在体外能明显促进人外周血白细胞吞噬金黄色葡萄球菌的能力.合成鱼腥草素能提高慢性气管炎患者白细胞的吞噬功能,提高家兔及患者血清备解素水平。
9、抗肿瘤作用:新鱼腥草素对艾氏腹水癌的抑制效果可能与提高癌细胞中的cAMP水平有关.实验表明:在不同时间对小鼠腹腔注射不同剂量的新鱼腥草素,其癌细胞总数、癌细胞分裂指数、腹水量均有明显降低,而癌细胞内的cAMP水平却有增高。
10、抗炎作用:鱼腥草煎剂对大鼠甲醛性脚肿有显著抗炎作用,亦能显著抑制人γ-球蛋白在Cu++存在下的热变性;鱼腥草素能显著抑制巴豆油、二甲苯所致小鼠耳肿胀、皮肤毛细血管通透性增加,对HCA引起的腹腔毛细血管染料渗出也有显著抑制作用.鱼腥草所含槲皮素、槲皮甙及异槲皮甙等黄酮类化合物亦有显著抗炎作用,能显著抑制炎症早期的毛细血管亢进。
11、其他作用:鱼腥草油能明显拮抗慢反应物质(SRS-A)对离体豚鼠回肠的作用,能明显抑制致敏豚鼠离体回肠的过敏性收缩,拮抗组胺、乙酰胆碱对豚鼠回肠的收缩,并对豚鼠过敏性哮喘有明显的保护作用。
鱼腥草水溶液皮下注射有轻度的镇静、抗惊作用,能抑制小鼠的自发运动,延长环己巴比妥钠睡眠时间,对抗士的宁所致惊厥;20~40mg/kg静注于犬可使其血压下降40~50mmHg(5.32~6.65kPa),并能抑制离体蟾蜍心脏.鱼腥草煎剂能抑制浆液分泌、促进组织再生;并有镇痛、止血作用.腹腔注射对氨水喷雾所致的小鼠咳嗽有止咳作用,但无祛痰平喘作用。
鱼腥草尚有镇痛、镇咳、止血、抑制浆液分泌,促进组织再生,伤愈合促进红皮病、银屑病的好转等作用,蕺菜碱有刺激皮肤发泡的作用。皮下注射鱼腥草水溶物还具有轻度的镇静、抗惊作用,能抑制小鼠的自发活动,延长环己巴比妥钠睡眠时间,对抗士的宁所致的惊厥,20-40mg/kg脉注射于犬可使血压下降40-50mmHg。
12、毒性:鱼腥草毒性很低,小鼠皮下注射的LD50是1.6±0.081g/kg,给体重17-20g的小鼠静脉注射1.5mg的鱼腥草素(相当于人体注射剂量的200倍左右),观察1周无死亡现象,且90%体重增加,经解剖亦未见病变发生。对犬静脉滴注38-47mg/kg不致引起死亡,剂量增至61-64mg/kg则可引起死亡,解剖可见肺部有严重出血和血栓。给犬皮下注射每日80-160mg/kg,连续lmo,可见有大量的流涎,早期常出现呕吐,对食欲、血象及肝肾功能等均无明显的影响。给犬灌胃,每日80-160mg/kg,连续1个月,可见有大量流涎现象,早期常出现呕吐,此外则未见异常。
(9)肉桂:
亦称中国肉桂(Chinese cinnamon)。樟科(Lauraceae)植物,学名为Cinnamomum cassia。树皮芳香,亦称肉桂,可作香料,味与产自斯里兰卡肉桂的桂皮相似,但较辣,不及桂皮鲜美,且较桂皮厚。
功效与作用
肉桂的功效:
补火助阳,引火归源,散寒止痛,活血通经。用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。主治肾阳不足;命门火畏寒肢冷;腰膝酸软;阳痿遗精;小便不利或频数;短气喘促;浮肿尿少诸证;命门火衰;火不归源;戴阳;格阳;及上热下寒;面赤足冷;头晕耳鸣;口舌糜破;脾肾虚寒;脘腹冷痛;食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛;宫冷不孕;痛经经闭;产后瘀滞腹痛;阴疽流注;或虚寒痈疡脓成不溃;或溃后不敛。
肉桂的作用:
1、对中枢神经系统的作用:桂皮醛以250-500mg/kg灌胃,能减少小鼠自发活动,对抗苯丙胺产生的过度活动;桂皮醛还可对抗阿朴吗啡及去氧麻黄碱的运动兴奋,使体温下降,但对抗利血平引起的体温下降;用小鼠压尾法或腹腔注射醋酸扭体法表明桂皮醛有镇痛作用;认为桂皮醛的中枢作用与中枢单胺能神经原的活动有关。
2、对心血管系统的作用:肉桂水提物及挥发油对大鼠在冰水应激状态下内源性儿茶酚胺分泌增加所致的血小板聚集及心肌损伤有一定对抗及保护作用;肉桂煎剂可使麻醉犬冠脉、脑血流量增加,血管阻力下降;肉桂煎剂、柱皮醛及香豆素对ADP诱导大鼠血小板聚集有抑制作用。
3、抗溃疡作用:肉桂水提物腹腔注射,可防止大鼠应激性溃疡,灌胃或腹腔注射也可抑制5-羟色胺引起的大鼠胃溃疡,抗溃疡作用不仅由於抑制胃液分泌,而且促进胃粘膜的血流量。
4、抗变态反应:肉桂水提物有抗变态反应的作用,对补体依赖性的反应如II型的反向皮肤过敏反应(RCA)、福斯曼皮肤血管炎(FCV)及III型的Arthus反应均有明显抑制作用。其他,肉桂的乙醚及乙醇浸出液对革兰氏阳性菌及真菌有抑菌作用。
肉桂的药理作用
1、对中枢神经系统的作用:
1.1.镇静作用:肉桂中含有的桂皮醛对小鼠有明显的镇静作用,表现为自发活动减少,对抗甲基苯丙胺(Methamphetamine)所产生的过多活动、转棒试验产生的运动失调以及延长环己巴比妥钠的麻醉时间等。应用小鼠压尾刺激或腹腔注射醋酸观察扭体运动的方法证明它有镇痛作用。
1.2.降温作用:对小鼠正常体温以及用伤寒、副伤寒混合疫苗引起的人工发热均有降温作用。对温刺引起发热的家兔,桂皮醛及肉桂酸钠都有解热作用。可延迟士的宁引起的强直性惊厥及死亡的时间,可减少菸碱引起的强直性惊厥及死亡的发生率。对戌四唑引起者则无效。
2、降压作用:附子、肉桂复方对肾上腺皮质性高血压大鼠(灼伤一侧肾上腺所形成之模型)有降压作用;对肾性高血压大鼠(8字形结扎肾脏所形成之模型),则无作用。此作用可能是附子、肉桂促进机能降低了的肾上腺活动,使之趋向正常所致。
3、预防血吸虫病的作用:小鼠每天口服浸剂(未注明品种)0.2ml/10g体重(10.8g/180ml),共服15天,服药之第3天感染血吸虫,并无预防作用,如与雄黄、槟榔及阿魏同用则有一定效果。
4、对血液的作用:肉桂体外及体内试验,均有明显抑制ADP诱导的大鼠血小板聚集的作用,体外试验显示肉桂水煎剂及溶甲醇部分有较强的抗凝作用。从肉桂中提取的单体-肉桂酸及香豆素,抗凝作用不明显。体内试验肉桂水煎剂也无抗凝作用,不影响兔纤维蛋白溶解活性。5.对消化系统的作用:
5.其他作用:
5.1.通经作用:大量桂皮油可引起子宫充血,显示通经作用,此为古本草说的坠胎作用提供了一个实验依据。
5.2.杀菌作用:桂皮油有强大杀菌作用,对革兰氏染色阳性菌的效果比阴性者好,因有刺激性,很少用作抗菌药物,但外敷可治疗胃痛、胃肠胀气绞痛等。
5.3.健胃和驱风剂:内服可作健胃和驱风剂。也有明显的杀真菌作用,曾应 用含1.5%桂皮油及0.5%麝香草酚的混合物治疗头癣。桂皮醛及肉桂酸钠可引起蛙足蹼膜血管扩张及家兔白细胞增加。
5.4.祛痰镇咳作用:桂皮油吸收后由肺排出,使粘液稀释,呈现祛痰镇咳作用。
5.5.利尿作用:从肾排出而致局部刺激,显示一定的利尿作用。
5.6.抗放射作用:桂皮酸钠对给小鼠和狗一次全身照射钴60,丙种射线的致死量的实验,证明有抗放射作用。
(10)生姜:
生姜性温,其特有的“姜辣素”能刺激胃肠黏膜,使胃肠道充血,消化能力增强,能有效地治疗吃寒凉食物过多而引起的腹胀、腹痛、腹泻、呕吐等。吃过生姜后,人会有身体发热的感觉,这是因为它能使血管扩张,血液循环加快,促使身上的毛孔张开,这样不但能把多余的热带走,同时还把体内的病菌、寒气一同带出。当身体吃了寒凉之物,受了雨淋或在空调房间里呆久后,吃生姜就能及时消除因肌体寒重造成的各种不适。
生姜的功效:发汗解表,温中止呕,温肺止咳,解鱼蟹毒,解药毒。功用:为芳香性辛辣健胃药,有温暖、兴奋、发汗、止呕、解毒等作用,特别对于鱼蟹毒,半夏、天南星等药物中毒有解毒作用。适用于外感风寒、头痛、痰饮、咳嗽、胃寒呕吐;在遭受冰雪、水湿、寒冷侵袭后,急以姜汤饮之,可增进血行,驱散寒邪。
生姜的作用:
1、降温提神增进食欲:因为姜中含有姜醇、姜烯、水芹烯、柠檬醛和芳香等油性的挥发油;还有姜辣素、树脂、淀粉和纤维等。所以,姜在炎热时节有兴奋、排汗降温、提神等作用;可缓解疲劳、乏力、厌食、失眠、腹胀、腹痛等症状;生姜还有健胃,增进食欲的作用,夏令气候炎热,唾液、胃液的分泌会减少,因而影响人的食欲,如果在吃饭时食用几片生姜,会增进食欲;生姜对胃病亦有缓解或止痛作用,胃炎及胃十二指肠溃疡所引发的疼痛、呕吐、泛酸、饥饿感等用生姜50克煎水喝,可使症状迅速消除。
2、抗菌防病治疗肠炎:美国和丹麦的科学家通过试验证实,生姜干粉可缓解晕动病之头痛、眩晕、恶心、呕吐等症状,有效率达90%左右,且药效可持续4小时以上。民间用吃生姜的办法防止晕车、晕船,有的用生姜片贴内关穴,有明显的防晕效果。盛夏季节,细菌生长繁殖异常活跃,容易污染食物而引起急性肠胃炎,此时适当吃些生姜或用干姜加茶用沸水冲泡后饮用,能起到防治作用。科学家通过研究发现,生姜能起到某些抗菌素的作用,尤其对沙门氏菌效果明显。生姜还有杀灭口腔致病菌和肠道致病菌的作用,用生姜水含漱治疗口臭和牙周炎,疗效显著。
3、开胃健脾防暑救急:夏天,人们贪凉,喜爱电扇空调对着吹,很容易受寒,引起感冒。这时及时喝点姜糖水,将有助于驱逐体内风寒。中医认为生姜能“通神明”,即提神醒脑。夏季中暑昏厥不省人事时,用姜汁一杯灌下,能使病人很快醒过来。对一般暑热,表现为头昏、心悸及胸闷恶心的病人,适当吃点生姜汤大有裨益。我国传统的防暑中成药——人丹,里面就含有生姜的成分,目的就是驱风健胃和提神醒脑。
(11)白砂糖:
糖是用甘蔗或甜菜等植物加工而成的一种调味品,其主要成分是蔗糖。白砂糖是食糖中质量最好的一种。其颗粒为结晶状,均匀,颜色洁白,甜味纯正,甜度稍低于红糖。 烹调中常用。绵白糖为粉末状,适合于烹调之用,甜度与白砂糖差不多。绵白糖有精制绵白糖和土法制的绵白糖两种。前者色泽洁白,晶粒细软,质量较好;后者色泽微黄稍暗,质量较差。白砂糖和绵白糖只是结晶体大小不同,白砂糖的结晶颗粒大,含水分很少,而绵白糖的结晶颗粒小,含水分较多。
白砂糖营养分析:
1.适当食用白糖有助于提高机体对钙的吸收,但过多就会妨碍钙的吸收;
2.吃糖后应及时漱口或刷牙,以防龋齿的产生;
3.糖尿病病人不易直接食用食糖,最好是以甜味剂替代。
(12)绿茶:
绿茶是指采取茶树新叶,未经发酵,经杀青、揉拧、干燥等典型工艺,其制成品的色泽,冲泡后茶汤较多的保存了鲜茶叶的绿色主调。常饮绿茶能防癌和降血脂,防电脑辐射。吸烟者可减轻尼古丁伤害。
功效与作用:
绿茶我国被誉为“国饮”。现代科学大量研究证实,茶叶确实含有与人体健康密切相关的生化成份,茶叶不仅具有提神清心、清热解暑、消食化痰、去腻减肥、清心除烦、解毒醒酒、生津止渴、降火明目、止痢除湿等药理作用,还对现代疾病,如辐射病、心脑血管病、癌症等疾病,有一定的药理功效。茶叶具有药理作用的主要成份是茶多酚、咖啡碱、脂多糖、茶氨酸等。
具体作用有:
1、有助于延缓衰老茶多酚具有很强的抗氧化性和生理活性,是人体自由基的清除剂。据有关部门研究证明1毫克茶多酚清除对人肌体有害的过量自由基的效能相当于9微克超氧化物歧化酶(SOD),大大高于其它同类物质。茶多酚有阻断脂质过氧化反应,清除活性酶的作用。据日本奥田拓勇试验结果,证实茶多酚的抗衰老效果要比维生素E强18倍。
2、有助于抑制心血管疾病茶多酚对人体脂肪代谢有着重要作用。人体的胆固醇、三酸甘油脂等含量高,血管内壁脂肪沉积,血管平滑肌细胞增生后形成动脉粥样化斑块等心血管疾病。茶多酚,尤其是茶多酚中的儿茶素ECG和EGC及其氧化产物茶黄素等,有助于使这种斑状增生受到抑制,使形成血凝黏度增强的纤维蛋白原降低,凝血变清,从而抑制动脉粥样硬化。
3、有助于预防和抗癌茶多酚可以阻断亚硝酸铵等多种致癌物质在体内合成,并具有直接杀伤癌细胞和提高肌体免疫能力的功效。据有关资料显示,茶叶中的茶多酚(主要是儿茶素类化合物),对胃癌、肠癌等多种癌症的预防和辅助治疗,均有裨益。
4、有助于预防和治疗辐射伤害茶多酚及其氧化产物具有吸收放射性物质锶90和钴60毒害的能力。据有关医疗部门临床试验证实,对肿瘤患者在放射治疗过程中引起的轻度放射病,用茶叶提取物进行治疗,有效率可达90%以上;对血细胞减少症,茶叶提取物治疗的有效率达81.7%;对因放射辐射而引起的白血球减少症治疗效果更好。
5、有助于抑制和抵抗病毒菌茶多酚有较强的收敛作用,对病原菌、病毒有明显的抑制和杀灭作用,对消炎止泻有明显效果。我国有不少医疗单位应用茶叶制剂治疗急性和慢性痢疾、阿米巴痢疾、流感,治愈率达90%左右。
6、有助于美容护肤茶多酚是水溶性物质,用它洗脸能清除面部的油腻,收敛毛孔,具有消毒、灭菌、抗皮肤老化,减少日光中的紫外线辐射对皮肤的损伤 等功效。
7、有助于醒脑提神茶叶中的咖啡碱能促使人体中枢神经兴奋,增强大脑皮层的兴奋过程,起到提神益思、清心的效果。
8、有助于利尿解乏茶叶中的咖啡碱可刺激肾脏,促使尿液迅速排出体外,提高肾脏的滤出率,减少有害物质在肾脏中滞留时间。咖啡碱还可排除尿液中的过量乳酸,有助于使人体尽快消除疲劳。
9、有助于降脂助消化唐代《本草拾遗》中对茶的功效有“久食令人瘦”的记载。我国边疆少数民族有“不可一日无茶”之说。因为茶叶有助消化和降低脂肪的重要功效,用当今时尚语言说,就是有助于“减肥”。这是由于茶叶中的加啡碱能提高胃液的分泌量,可以帮助消化,增强分解脂肪的能力。所谓“久食令人瘦”的道理就在这里。
10、有助于护齿明目茶叶中含氟量较高,每100克干茶中含氟量为10毫克——15毫克,且80%为水溶性成份。若每人每天饮茶叶10克,则可吸收水溶性氟1毫克——1.5毫克,而且茶叶是碱性饮料,可抑制人体钙质的减少,这对预防龋齿、护齿、坚齿,都是有益的。据有关资料显示,在小学生中进行“饮后茶疗漱口”试验,龋齿率可降低80%。另据有关医疗单位调查,在白内障患者中有饮茶习惯的占28.6%;无饮茶习惯的则占71.4%。这是因为茶叶中的维生素C等成份,能降低眼睛晶体混浊度,经常饮茶,对减少眼疾、护眼明目均有积极的作用。
一般人均可饮用:
适宜高血压、高血脂、冠心病、动脉硬化、糖尿病、油腻食品食用过多者、醉酒者;不适宜发热、肾功能不良、心血管疾病、习惯性便秘、消化道溃疡、神经衰弱、失眠、孕妇、哺乳期妇女、儿童。
1、绿茶已经成为最流行的保健品:特别是一些广告铺天盖地的渲染效应以及以绿茶为主要成分的各种相关美容保健品的层出不穷,使一些人把绿茶当做护肤健体的最佳选择。对此,有关专家提醒广大女性消费者,时尚的潮流不能盲目跟从,绿茶本身作为保健品来说,没有任何对健康的伤害,但是如果被各个商家与其他原料一起制成产品,对其的使用,就该注意把握一些细节了。
2、绿茶护肤品好功效,有效期有限虽然绿茶护肤品效果不错,但在选择此类产品时也应有些注意之处。在绿茶中起护肤美容功效的,主要是其中一种称为茶多酚的物质,这种物质具有抗氧化效果,与维生素B、E等配合,能起到补充水分紧实肌肤等作用。但要注意的是,茶多酚作为酚类物质或其衍生物的总称,在空气中很容易挥发,而丧失其抗氧化作用,所以此类护肤品,尤其是面膜,以当年的新茶制品为最好。
3、饮用绿茶减肥防病,但经期慎饮:绿茶中含有一定的咖啡因,和茶多酚并存时,能制止咖啡因在胃部产生作用,避免刺激胃酸的分泌,使咖啡因的弊端不在体内发挥,但却促进中枢神经、心脏与肝脏的功能。而且,绿茶中的芳香族化合物还能溶解脂肪,防止脂肪积滞体内,咖啡因还能促进胃液分泌,有助消化与消脂。但女性在经期最好不要多饮用。有研究称,除了人体正常的铁流失外,女性每次月经期还要额外损失18~21毫克的铁。而在月经期间多喝绿茶,绿茶中较多的鞣酸成分,就会与食物中的铁分子结合,形成大量沉淀物,妨碍肠道黏膜对铁分子的吸收,并且,绿茶越浓,对铁吸收的阻碍作用就越大。
(13)糊精:
淀粉经酶法或化学方法水解得到的降解产物,为数个至数十个葡萄糖单位的寡糖和聚糖的混合物。包括有麦芽糖糊精、极限糊精等。
糊精是用来衡量原料蒸煮工艺的技术用语。淀粉在受到加热、酸或淀粉酶作用下发生分解和水解时,将大分子的淀粉首先转化成为小分子的中间物质,这时的中间小分子物质,人们就把它叫做糊精。
属于药用附加剂,用于治疗稀释剂、粘合剂。
基本介绍:
糊精通常分为三类:白糊精、黄糊精和英国胶或称“不列颠胶”。它们之间的差异在于对淀粉的预处理方法及热处理条件不同。
糊精广泛应用于医药、食品、造纸、铸造、壁纸、标签、邮票、胶带纸等的粘合剂。在作药片粘合剂时,需要快速干燥,快速散开,快速粘合及再湿可溶性,可选择白糊精或低粘度黄糊精产品。在作标签、邮票粘合剂时,需要粘度高,形成的薄膜具有强韧性,适宜用白糊精或英国胶。糊精在纺织印染中可作为印花糊料。
干糊精是一种黄白色的粉末,它不溶于酒精,而易溶于水,溶解在水中具有很强的粘性,淀粉质原料在进行蒸煮时,淀粉分子受热分解,首先就生成了糊精。这时如果加入一滴碘时,溶液就会呈红紫色,而不是象淀粉遇碘那样呈蓝色。
生产上通常把淀粉质原料在高温、高压下进行蒸煮,使淀粉细胞彻底破裂,淀粉由颗粒状态变为液糊状糊精的过程就叫做原料的糊化。其糊化程度用糊化率来表示。
糊化率=糊精或可溶性碳水化合物x100%/总糖
一、制法:淀粉预处理→干燥→热处理→冷却→成品(糊精)
(1)白糊精的反应温度较低,PH值较低,有色产物较少。
(2)黄糊精是低PH值及高温下高度转化产品。
二、性质:
(1)白糊精有一个很宽的粘度范围,随着转化度的提高,粘度逐渐下降。
(2)黄糊精当转化作用使溶解度达到100%时,粘度降低,速度减慢,最后降到一定值。
1、麦芽糊精的成分与作用:
麦芽糊精(也称为麦特灵)是由淀粉经低度水解、净化、喷雾干燥制成,不含游离淀粉的淀粉衍生物。英文简称为MD.具有粘性大、增稠性强、溶解性好、速溶性佳、载体性好、发酵小、吸潮性低、无异味、甜度低,人体易于消化吸收、低热、低脂肪等特点,是食品工业中最理想的基础原料之一,并在造纸工业、日用化工、精细化工、医药工业中得到越来越广泛的应用。
糖果类在糖果制造中加入适量的麦芽糊精,可以防止糖果″返砂″″烊化″增强糖果的弹性和韧性、改变风味、改善口感、预防潮解、消除粘牙现象,减少牙病,延长糖果的货架存放期。
婴儿食品类用于奶粉等婴儿食品中,可减少营养的损失、改善口感,能满足儿童的实际需要,促进儿童的健康成长。
冰冻食品类可增强冰淇淋的粘性,使产品膨松、细腻,提高乳化效果;在冰棒、冰果制作中加入麦芽糊精,可抗结晶、提高冻结温度、加强风味、改善口感。
固体饮料、调味料、香精类作为速溶麦片、奶粉、鸡精等食品的粘合剂和填充剂,可提高产品的溶解性能,改善口感和风味,防止产品潮解。
饼干、西点类以麦芽糊精代替砂糖,在糕饼、脆饼等低水份(10%以下)的产 品中应用,可控制面团的粘度、形成较佳的口感,避免干化、脆化。在松软饼干、蛋糕等水分含量10%以上的产品中应用,可增加面团粘度,帮助成形、控制甜度、避免反糖。同时,使产品达到良好的色泽,保水性良好。
液体饮料类液体饮料以麦芽糊精作为制作原料,可增加产品的稠度,稳定产品的结构,改善口感和风味。
麦芽糊精在造纸工业中的应用麦芽糊精具有较好的流动性及较强的粘合能力,在国外已将其应用于造纸行业中,作为表面的施胶剂和涂布(纸)涂料的粘合剂,国内有的造纸厂将其应用于铜版纸的生产,用于表面旋胶时,不但吸附在纸面纤维上,同时也向纸内渗透,提高纤维间的粘合力,改善外观及物理性能。用它代替先前的干酪素或聚乙烯醇,可显著降低生产成本和能耗。
2、环糊精的成分与作用:
环糊精是环糊精转葡萄糖基酶(CGTase)作用于淀粉的产物,是由六个以上葡萄糖以α-1,4-糖苷键连结的环状寡聚糖,其中最常见、研究最多的是α-环糊精(α-cyclodextrin)、β-环糊精(β-cyclodextrin)、γ-环糊精(γ-cyclodextrin),分别由六个、七个和八个葡萄糖分子构成,是相对大和相对柔性的分子。经X射线衍射和核磁共振研究,证明环糊精分子成锥柱状或圆锥状花环,有许多可旋转的键和羟基,内有一个空腔,表观外型类似于接导管的橡胶塞。空腔内部排列着配糖氧桥原子,氧原子的非键电子对指向中心,使空腔内部具有很高的电子密度,表现出部分路易斯碱的性质。分子构型为葡萄糖的C-1椅式构型,在它的圆筒内部有-CH-葡萄糖苷结合的0原子,故呈疏水性。葡萄糖的2位和3位的-OH基在圆筒的一端开口处,6位的-0H基在圆筒的另一端开口处,所以圆筒的二端开口处都呈亲水性,这样,环糊精的筒形体的内部上层、中层、下层由不同的基团组成。
环糊精的性质有点类似淀粉,可以贮存多年不变质。在强碱性溶液中也可稳定存在,在酸性溶液中则部分水解成葡萄糖和非环麦芽糖。由于环糊精没有还原性末端,总的来说,其反应活性是比较低的,只有少数的酶能是它明显水解。环糊精在室温下的的溶解度从1.8-25.6克不等,水溶液具有旋光性。环糊精的稳定性一般,200摄氏度左右时分解。
3、糊精在浆料中起什么作用:
糊精是淀粉分解的中间产物,其化学分子式与淀粉相同都是(C6H1005)n,但聚合度介于可溶性淀粉与麦芽糖之间,遇碘呈红色.聚合度低的糊精不发生显色反应。
糊精分为黄糊精和白糊精两大类。直接焙烧而得的糊精俗称“不列颠胶”,也可叫焙烧糊精,呈褐色。加酸焙烧,可在较低温度下分解。所得产品颜色一般为浅黄色或白色,称白糊精。
糊精的主要用途是作为胶粘剂,经纱上浆有用糊精作淀粉的添加物,目的是降低淀粉的黏度,提高浆液的浸透性,加入糊精的淀粉浆易退浆,但粘着力较差,浆膜较脆硬。常与PVA混合用于粘胶纤维纱和铜氨纤维长丝上浆,分纱时不易起毛。合成浆料及变性淀粉广泛使用后,在经纱上浆的配方中很少使用糊精。
(14)淀粉:
淀粉是葡萄糖的高聚体,在餐饮业又称芡粉,通式是(C6H1005)n,水解到二糖阶段为麦芽糖,化学式是(C12H22011),完全水解后得到葡萄糖,化学式是(C6H1206)。淀粉有直链淀粉和支链淀粉两类。淀粉是植物体中贮存的养分,贮存在种子和块茎中,各类植物中的淀粉含量都较高。 淀粉可以看作是葡萄糖的高聚体。淀粉除食用外,工业上用于制糊精、麦芽糖、葡萄糖、酒精灯,也用于调制印花浆、纺织品的上浆、纸张的上胶、药物片剂的压制等。可由玉米、甘薯、野生橡子和葛根等含淀粉的物质中提取而得。
淀粉有直链淀粉和支链淀粉两类。直链淀粉含几百个葡萄糖单元,支链淀粉含几千个葡萄糖单元。在天然淀粉中直链的占20%~26%,它是可溶性的,其余的则为支链淀粉。当用碘溶液进行检测时,直链淀粉液呈显蓝色,而支链淀粉与碘接触时则变为红棕色。(原因是:具有长螺旋段的直链淀粉可与长链的聚I3-形成复合物并产生蓝色。直链淀粉-碘复合物含有19%的碘。支链淀粉与碘复合生成微红-紫红色,这是因为支链淀粉的支链对于形成长链的聚I3-而言是太短了。)
淀粉是植物体中贮存的养分,贮存在种子和块茎中,各类植物中的淀粉含量都较高,大米中含淀粉62%~86%,麦子中含淀粉57%~75%,玉蜀黍中含淀粉65%~72%,马铃薯中则含淀粉超过90%。淀粉是食物的重要组成部分,咀嚼米饭等时感到有些甜味,这是因为唾液中的淀粉酶将淀粉水解成了二糖-麦芽糖。食物进入胃肠后,还能被胰脏分泌出来的唾液淀粉酶水解,形成的葡萄糖被小肠壁吸收,成为人体组织的营养物。支链淀粉部分水解可产生称为糊精的混合物。糊精主要用作食品添加剂、胶水、浆糊,并用于纸张和纺织品的制造(精整)等。
淀粉燃点约为380℃。
淀粉在制剂制备中的应用:
总体来说,淀粉具有不溶于水、水中分散、60~70℃溶胀的特点。常被用作稀释剂、粘合剂、崩解剂,并可用来制备糊精和淀粉浆。
1、用作稀释剂(Diluents):稀释剂(或称为填充剂,Fillers)的主要作用是用来填充片剂的重量或体积,以便于制剂成型和分剂量,从而便于压片;常用的填充剂有淀粉类、糖类、纤维素类和无机盐类等。
以淀粉作为稀释剂时,比较常用的是玉米淀粉,它的性质非常稳定,与大多数药物不起作用,价格也比较便宜,吸湿性小、外观色泽好,在实际生产中,常与可压性较好的糖粉、糊精混合使用,这是因为淀粉的可压性较差,若单独使用,会使压出的药片过于松散。
2、用作粘合剂(Adhesives):某些药物粉末本身不具有粘性或粘性较小,需要加入淀粉浆等粘性物质,才能使其粘合起来,这时所加入的粘性物质就称为粘合剂。
淀粉浆(俗称淀粉糊)是片剂中最常用的粘合剂,常用8%~15%的浓度,并以10%淀粉浆最为常用;若物料可压性较差,可再适当提高淀粉浆的浓度到20%,相反,也可适当降低淀粉浆的浓度,如氢氧化铝片即用5%淀粉浆作粘合剂。淀粉浆的制法主要有煮浆和冲浆两种方法,都是利用了淀粉能够糊化的性质。所谓糊化(Gelatinization)是指淀粉受热后形成均匀糊状物的现象(玉米淀粉完全糊化的温度是77℃)。糊化后,淀粉的粘度急剧增大,从而可以作为片剂的粘合剂使用。具体说来,冲浆是将淀粉混悬于少量(1~1.5倍)水中,然后根据浓度要求冲入一定量的沸水,不断搅拌糊化而成;煮浆是将淀粉混悬于全部量的水中,在夹层容器中加热并不断搅拌(不宜用直火加热,以免焦化),直至糊化。因为淀粉价廉易得且粘合性良好,所以凡在使用淀粉浆能够制粒并满足压片要求的情况下,大多数选用淀粉浆这种粘合剂。
3、用作崩解剂(Disintegrants):崩解剂是使片剂在胃肠液中迅速裂碎成细小颗粒的物质,除了缓(控)释片以及某些特殊用途的片剂以外,一般的片剂中都 应加入崩解剂。由于它们具有很强的吸水膨胀性,能够瓦解片剂的结合力,使片剂从一个整体的片状物裂碎成许多细小的颗粒,实现片剂的崩解,所以十分有利于片剂中主药的溶解和吸收。
干淀粉是一种最为经典的崩解剂,含水量在8%以下,吸水性较强且有一定的膨胀性,较适用于水不溶性或微溶性药物的片剂,但对易溶性药物的崩解作用较差,这是因为易溶性药物遇水溶解产生浓度差,使片剂外面的水不易通过溶液层面透入到片剂的内部,阻碍了片剂内部淀粉的吸水膨胀。在生产中,一般采用外加法、内加法或“内外加法”来达到预期的崩解效果。
淀粉作为片剂崩解剂的缺点:首先,淀粉的可压性不好,用量多时,可影响片剂的硬度。其次,淀粉的流动性不好,外加淀粉过多会影响颗粒的流动性。
4、制备糊精:糊精(C6H1005)x,由淀粉经酸或热处理或经a-淀粉酶作用而成的不完全水解的产物,可用于制备各种液体或固体的胶粘剂。
经科学筛选后的上述配方与其它配方相比,经人体临床实验见效性强,效果明显。
经人体实验,实验结论:30例免疫力低下的受试者要求服用可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂30天,免疫力得到明显改善,及增强免疫力、滋阴补血、调经止痛,又去瘀生新,利尿消肿,同时也改善血液供氧循环,且肠胃功能的到显著改善,说明可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂有增强免疫力的作用。可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂试食用后,血常规、尿常规及血生化指标均在正常范围,说明本品为受试者身体健康无不良影响。
可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,每日服用量为每日三次,每次两粒。主要食用人群为免疫力低下者。
本发明与现有可增强免疫力、抗病原微生物、抗病毒的配方相比有以下方面的突出特点:本发明采用复方形式,精心选料,严谨组方,追求整体改善人体状况,从增强免疫力、润肠通便、活血化瘀、养阴生津等方面全面调整身体状况。人体气血运行通畅,代谢正常。白芷祛风燥湿,消肿止痛;金银花抗炎和解热作用;枸杞子延缓衰老,调节血脂和血糖;薄荷清凉止痒,消炎止痛;龙眼肉补益心脾,养血安神;天门冬养阴生津,润肺清心,除燥降火;麦门冬养阴生津,润肿清心;鱼腥草抗病毒、利尿、防辐射;肉桂补火助阳,散寒止痛,活血通经;生姜发汗解表,温中止呕;桃仁破血行瘀,润燥滑肠;绿茶能防癌和降血脂,防电脑辐射;糊精作为胶粘剂,目的是降低淀粉的黏度,提高浆液的浸透性;淀粉常被用作稀释剂、粘合剂、崩解剂,并可用来制备糊精和淀粉浆。组方从整体上改善身体状况,抗病原微生物、抗病毒、增强免疫力。
二、本发明工艺先进,剂型高档时尚。
本配方的相关原料经提取后调配,缩小了体积,便于生产,较为先进。选用胡麻油作溶剂,增强了本配方的功效。胡麻油含有很高的不饱和脂肪酸,亚麻酸含量在55%-60%,是天然保健食品,对心血管系统有保护作用,还有很广泛的保健作用,能调解血糖、血脂、血压,补脑、保护视力等。
采用颗粒剂剂型,既能最大限度的保护有效成份,又能便于服用和消化吸收,剂型高档时尚。
与本类发明相关的现有的可增强免疫力、抗病原微生物、抗病毒的茶饮料的配方大部分采用熟地黄、当归、何首乌、亚麻酸等单一成分,而此类配方存在的问题是增效性较差,而本发明比较全面,配方增加了桃仁、黄精、决明子、麦门冬、郁李仁,互补性强,增效性强。
具体实施方式:
以下所示之最佳实施例作进一步详述:
投料生产5-10g/袋软胶囊100袋,有如下重量份组成:
实施例1,一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,包括:白芷提取物10重量份、金银花提取物10重量份、枸杞子提取物20重量份、薄荷提取物30重量份、龙眼肉提取物30重量份、天门冬提取物30重量份、糊精300重量份、麦门冬提取物20重量份、肉桂提取物20重量份、生姜提取物10重量份、淀粉390重量份、白砂糖20重量份、绿茶提取物100重量份、鱼腥草提取物10重量份;
实施例2,一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,包括:白芷提取物20重量份、金银花提取物20重量份、枸杞子提取物20重量份、薄荷提取物20重量份、龙眼肉提取物20重量份、天门冬提取物20重量份、糊精300重量份、麦门冬提取物20重量份、肉桂提取物20重量份、生姜提取物20重量份、淀粉380重量份、白砂糖20重量份、绿茶提取物100重量份、鱼腥草提取物20重量份;
实施例3,一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,包括:白芷提取物10重量份、金银花提取物20重量份、枸杞子提取物20重量份、薄荷提取物20重量份、龙眼肉提取物20重量份、天门冬提取物20重量份、糊精400重量份、麦门冬提取物20重量份、肉桂提取物20重量份、生姜提取物20重量份、淀粉290重量份、白砂糖20重量份、绿茶提取物100重量份、鱼腥草提取物20重量份;
实施例4,一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,包括:白芷提取物30重量份、金银花提取物30重量份、枸杞子提取物30重量份、薄荷提取物30重量份、龙眼肉提取物30重量份、天门冬提取物30重量份、糊精300重量份、麦门冬提取物30重量份、肉桂提取物20重量份、生姜提取物20重量份、淀粉300重量份、白砂糖20重量份、绿茶提取物100重量份、鱼腥草提取物30重量份;
实施例5,一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,包括:白芷提取物15重量份、金银花提取物20重量份、枸杞子提取物15重量份、薄荷提取物30重量份、龙眼肉提取物30重量份、天门冬提取物25重量份、糊精400重量份、麦门冬提取物15重量份、肉桂提取物20重量份、生姜提取物10重量份、淀粉290重量份、白砂糖15重量份、绿茶提取物85重量份、鱼腥草提取物30重量份;
一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂的制备方法。包括如下步骤:
(1)原料制备
将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶分别进行精选,漂洗两次,淋去水分;在温度为60~80℃烘干1.5-2小时,使其水分为5-6%,粗粉碎后粒度为5-50mm加水是物料的8倍,浸提2-8小时,提取2次;将两次过滤液合并,浓缩,在温度为60-80℃烘干1.5-2小时,使其含水分为5-6%;粉碎、过筛,粒度为0.1-0.5mm,为中药提取物细粉。
(2)将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶等提取物和糊精、淀粉、白沙糖按比例混合均匀后,干燥、整粒、过筛;
(3)过筛后按每袋5-10克装袋;
(4)灭菌装箱;
(5)检验合格后装箱入库、销售。
Claims (4)
1.一种可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,其特征是包括有如下重量份的原料:白芷提取物10-30重量份、金银花提取物10-30重量份、枸杞子提取物10-30重量份、薄荷提取物10-30重量份、龙眼肉提取物10-30重量份。
2.如权利要求1所述的可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,其特征在于还包括有如下重量份的原料:天门冬提取物10-30重量份、麦门冬提取物10-30重量份、肉桂提取物10-20重量份、生姜提取物10-20重量份、糊精300-400重量份。
3.如权利要求1和2所述的可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂,其特征在于还包括有如下重量份的原料:淀粉300-400重量份、白砂糖10-20重量份、绿茶提取物10-100重量份、鱼腥草提取物10-30重量份。
4.如权利要求1至3所述的可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂的制备方法,其特征在于,还包括如下步骤:
(1)原料制备
将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶分别进行精选,漂洗两次,淋去水分;在温度为60~80℃烘干1.5-2小时,使其水分为5-6%,粗粉碎后粒度为5-50mm加水是物料的8倍,浸提2-8小时,提取2次;将两次过滤液合并,浓缩,在温度为60-80℃烘干1.5-2小时,使其含水分为5-6%;粉碎、过筛,粒度为0.1-0.5mm,为中药提取物细粉。
(2)将白芷、金银花、枸杞子、薄荷、龙眼肉、天门冬、麦门冬、鱼腥草、肉桂、生姜、绿茶等提取物和糊精、淀粉、白砂糖按比例混合均匀后,干燥、整粒、过筛。
(3)过筛后按每袋5-10克装袋。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012103764624A CN103168883A (zh) | 2012-09-24 | 2012-09-24 | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012103764624A CN103168883A (zh) | 2012-09-24 | 2012-09-24 | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103168883A true CN103168883A (zh) | 2013-06-26 |
Family
ID=48629431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012103764624A Pending CN103168883A (zh) | 2012-09-24 | 2012-09-24 | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103168883A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104406978A (zh) * | 2014-12-31 | 2015-03-11 | 青海康普生物科技股份有限公司 | 一种枸杞多糖真伪鉴别的简易方法 |
CN104547158A (zh) * | 2015-01-30 | 2015-04-29 | 黄瑞兰 | 一种百草丹 |
CN104547845A (zh) * | 2013-10-15 | 2015-04-29 | 青岛博研达工业技术研究所(普通合伙) | 一种增强免疫力的清热活血中药 |
CN104877448A (zh) * | 2015-06-03 | 2015-09-02 | 王金海 | 一种感光阻焊油墨及其制备方法 |
CN105995363A (zh) * | 2016-06-29 | 2016-10-12 | 王啸天 | 一种金银花薄荷水风味饮料及其制备方法 |
CN106259796A (zh) * | 2016-10-17 | 2017-01-04 | 内江职业技术学院 | 一种含有天冬多糖的保健蛋糕及其制作方法 |
CN108308602A (zh) * | 2018-01-29 | 2018-07-24 | 斯汏克(北京)生物科技有限公司 | 一种增强免疫力复合益生菌植物酵素饮品的制备方法 |
CN111328957A (zh) * | 2020-03-10 | 2020-06-26 | 石家庄洛杉奇食品有限公司 | 一种抑菌防腐组合物及其制备方法和应用 |
CN112262943A (zh) * | 2020-10-26 | 2021-01-26 | 朱怀杰 | 一种姜桂安抗氧化固体饮的复合配方及制作工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426787A (zh) * | 2001-12-20 | 2003-07-02 | 肖永良 | 抗疲劳增强免疫的保健混合物 |
CN1802969A (zh) * | 2006-01-24 | 2006-07-19 | 贾灯喜 | 保健茶及其生产方法 |
CN101703228A (zh) * | 2009-11-10 | 2010-05-12 | 赵祎乾 | 一种增强免疫力的保健组合物及其制备方法 |
CN101849593A (zh) * | 2010-05-18 | 2010-10-06 | 山西省屯留县科技情报服务中心 | 一种保健茶及其制作方法 |
-
2012
- 2012-09-24 CN CN2012103764624A patent/CN103168883A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426787A (zh) * | 2001-12-20 | 2003-07-02 | 肖永良 | 抗疲劳增强免疫的保健混合物 |
CN1802969A (zh) * | 2006-01-24 | 2006-07-19 | 贾灯喜 | 保健茶及其生产方法 |
CN101703228A (zh) * | 2009-11-10 | 2010-05-12 | 赵祎乾 | 一种增强免疫力的保健组合物及其制备方法 |
CN101849593A (zh) * | 2010-05-18 | 2010-10-06 | 山西省屯留县科技情报服务中心 | 一种保健茶及其制作方法 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547845A (zh) * | 2013-10-15 | 2015-04-29 | 青岛博研达工业技术研究所(普通合伙) | 一种增强免疫力的清热活血中药 |
CN104406978A (zh) * | 2014-12-31 | 2015-03-11 | 青海康普生物科技股份有限公司 | 一种枸杞多糖真伪鉴别的简易方法 |
CN104547158A (zh) * | 2015-01-30 | 2015-04-29 | 黄瑞兰 | 一种百草丹 |
CN104877448A (zh) * | 2015-06-03 | 2015-09-02 | 王金海 | 一种感光阻焊油墨及其制备方法 |
CN105995363A (zh) * | 2016-06-29 | 2016-10-12 | 王啸天 | 一种金银花薄荷水风味饮料及其制备方法 |
CN106259796A (zh) * | 2016-10-17 | 2017-01-04 | 内江职业技术学院 | 一种含有天冬多糖的保健蛋糕及其制作方法 |
CN108308602A (zh) * | 2018-01-29 | 2018-07-24 | 斯汏克(北京)生物科技有限公司 | 一种增强免疫力复合益生菌植物酵素饮品的制备方法 |
CN111328957A (zh) * | 2020-03-10 | 2020-06-26 | 石家庄洛杉奇食品有限公司 | 一种抑菌防腐组合物及其制备方法和应用 |
CN111328957B (zh) * | 2020-03-10 | 2022-10-18 | 石家庄洛杉奇食品有限公司 | 一种抑菌防腐组合物及其制备方法和应用 |
CN112262943A (zh) * | 2020-10-26 | 2021-01-26 | 朱怀杰 | 一种姜桂安抗氧化固体饮的复合配方及制作工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
CN102784363B (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
CN102511869B (zh) | 红枣生姜浓浆 | |
KR20070111623A (ko) | 한약재 추출물을 유효성분으로 함유하는 관상동맥성 심장 질환 또는 동맥경화증의 예방 또는 치료용 약학 조성물 | |
CN105995283A (zh) | 一种抗雾霾、润肺组合物、饮品及其制备方法 | |
CN102657791B (zh) | 含密蒙花的中药组合物及其制备方法 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
KR20120131337A (ko) | 인진쑥, 헛개나무, 민들레, 대추, 갈근 및 오가피의 각각의 추출물을 주성분으로 함유하는 기능성 음료 조성물 | |
KR101930277B1 (ko) | 숙취 예방 및 개선용 조성물 | |
CN101507800A (zh) | 金线莲和南瓜复合降血糖保健品及其制备方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104857154A (zh) | 一种治疗“三高”症的中药组合物及其制备方法 | |
CN104474472B (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
KR20200061446A (ko) | 함초를 이용한 식품 조성물 및 그 제조방법 | |
CN104586977A (zh) | 苦丁茶颗粒剂及其生产方法 | |
KR101479096B1 (ko) | 생약혼합물의 추출물을 함유하는 산전산후부종 예방 또는 개선용 건강기능식품 | |
CN105125985A (zh) | 一种治疗老年慢性支气管炎的中西药复方制剂及其制备方法 | |
CN106177712A (zh) | 一种治疗心脑血管疾病的华蒜豆及其制备方法 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
CN104547494A (zh) | 治疗甲亢的中药组合物药酒及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130626 |